Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
2435 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 713 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
521 1372 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
5311068 1372 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
835 1372 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
CHEMBL778 1372 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
DB00633 1372 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
2435 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 713 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
218362 203082 5 None 1 3 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 203082 5 None 1 3 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
185076 186497 4 None 11 3 Human 8.9 pEC50 = 8.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 186497 4 None 11 3 Human 8.9 pEC50 = 8.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
521 1372 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
5311068 1372 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
835 1372 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
CHEMBL778 1372 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
DB00633 1372 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
44314198 103920 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 103920 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 100986 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 100986 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
2803 939 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 939 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 939 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 939 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 939 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
44292232 100838 0 None 1 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 100838 0 None 1 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
11140345 202461 0 None -12 5 Human 7.0 pEC50 = 7 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 202461 0 None -12 5 Human 7.0 pEC50 = 7 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
24906200 192543 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL523048 192543 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
11211035 84565 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL223836 84565 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
11211035 84565 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL223836 84565 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
10382537 202456 11 None 4 2 Human 7.9 pEC50 = 7.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 202456 11 None 4 2 Human 7.9 pEC50 = 7.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
44371864 50853 0 None 2 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 50853 0 None 2 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
1960 2805 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
439260 2805 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
505 2805 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
CHEMBL1437 2805 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
DB00368 2805 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
44352207 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44352207 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
44352207 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18653 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
1960 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
439260 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
505 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
CHEMBL1437 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
DB00368 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
9859437 167448 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 167448 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
1960 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
439260 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
505 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
CHEMBL1437 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
DB00368 2805 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
50994258 59758 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641682 59758 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1739118 59758 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
53323136 56268 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641690 56268 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
44312036 202849 0 None -19 2 Human 4.8 pEC50 = 4.8 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
CHEMBL72995 202849 0 None -19 2 Human 4.8 pEC50 = 4.8 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
24882007 12352 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
CHEMBL1186220 12352 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
56950526 71149 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1928323 71149 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1962709 71149 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
57400570 71143 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1928322 71143 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1962686 71143 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
44371755 48498 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48498 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24882106 12444 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2c1cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
CHEMBL1186774 12444 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2c1cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
118717249 114614 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
CHEMBL3343700 114614 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
11098175 202460 0 None -186 4 Human 6.7 pEC50 = 6.7 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202460 0 None -186 4 Human 6.7 pEC50 = 6.7 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
135399666 168187 4 None -89 7 Human 5.7 pEC50 = 5.7 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL437314 168187 4 None -89 7 Human 5.7 pEC50 = 5.7 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
3086326 202816 17 None 13 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 202816 17 None 13 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
131829 203010 11 None 37 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 203010 11 None 37 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
44314200 102466 0 None -9 3 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102466 0 None -9 3 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
53324490 59761 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641681 59761 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1739173 59761 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
10934575 202771 0 None -229 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 202771 0 None -229 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
11140347 202818 0 None -13 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 202818 0 None -13 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
11000184 12926 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 12926 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 12926 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11173568 84204 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222371 84204 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
135453290 133070 23 None -1318 8 Human 5.6 pEC50 = 5.6 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL371300 133070 23 None -1318 8 Human 5.6 pEC50 = 5.6 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
44449277 154632 2 None 1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402388 154632 2 None 1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
68712 99861 57 None -1 4 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 99861 57 None -1 4 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
44312037 202903 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 202903 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
2803 939 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
516 939 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
704 939 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
CHEMBL134 939 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
DB00575 939 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
11043720 91726 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 91726 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
11043720 91726 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 91726 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
124 2921 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2921 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2921 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2921 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2921 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2803 939 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
516 939 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
704 939 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
CHEMBL134 939 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
DB00575 939 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
2146 3039 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
485 3039 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
6041 3039 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
CHEMBL1215 3039 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
DB00388 3039 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
57402718 70830 2 None 3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 70830 2 None 3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
11265631 135873 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135873 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
11097789 102511 0 None -52 5 Human 6.5 pEC50 = 6.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102511 0 None -52 5 Human 6.5 pEC50 = 6.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
11265631 135873 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 135873 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
49836306 18373 0 None -31 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276247 18373 0 None -31 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
44449247 94957 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256984 94957 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
9817256 202527 0 None -251 2 Human 5.5 pEC50 = 5.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 202527 0 None -251 2 Human 5.5 pEC50 = 5.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
9971924 183634 0 None 1 2 Human 7.5 pEC50 = 7.5 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL48341 183634 0 None 1 2 Human 7.5 pEC50 = 7.5 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
44421258 84308 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84308 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84308 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
24882019 12446 2 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 2 3 0.7 Cc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1186788 12446 2 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 2 3 0.7 Cc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
1960 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
439260 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
505 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
CHEMBL1437 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
DB00368 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
1960 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
439260 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
505 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
CHEMBL1437 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
DB00368 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
1960 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
439260 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
505 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
CHEMBL1437 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
DB00368 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
1960 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
439260 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
505 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
CHEMBL1437 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
DB00368 2805 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
294234 102407 3 None 2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102407 3 None 2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
118717248 114613 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
CHEMBL3343699 114613 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
11140033 20468 0 None -4 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20468 0 None -4 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
11108001 10756 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10756 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10756 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
2435 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 713 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
11360447 84563 0 None 1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 84563 0 None 1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
10859076 13555 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13555 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13555 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44449276 95194 0 None -1 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257976 95194 0 None -1 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
11098175 202460 0 None -186 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202460 0 None -186 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
57391904 71122 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
CHEMBL1928316 71122 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
CHEMBL1962472 71122 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
44449691 95702 0 None -2 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL260576 95702 0 None -2 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
24906159 186812 12 None -3 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 186812 12 None -3 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
57400959 70829 0 None -1 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 70829 0 None -1 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
11265631 135873 0 None -9 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135873 0 None -9 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
1593 2298 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2298 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2298 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2298 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2298 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
11109088 202470 0 None -14 5 Human 8.2 pEC50 = 8.2 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 202470 0 None -14 5 Human 8.2 pEC50 = 8.2 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
57395731 70831 0 None 3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 70831 0 None 3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
49836305 18374 0 None -9 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18374 0 None -9 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
24906199 187072 12 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187072 12 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
44292386 100999 0 None -35 2 Human 7.2 pEC50 = 7.2 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297827 100999 0 None -35 2 Human 7.2 pEC50 = 7.2 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
17804479 95203 16 None -1 4 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258007 95203 16 None -1 4 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
50994260 59760 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
CHEMBL1641689 59760 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
CHEMBL1739136 59760 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
10333157 150694 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 150694 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
10333157 150694 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 150694 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11371902 141094 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
CHEMBL385310 141094 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
11371902 141094 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL385310 141094 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
23622576 172193 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172193 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
2803 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
2803 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
516 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
704 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
CHEMBL134 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
DB00575 939 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
10176999 103066 14 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103066 14 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
53322686 59762 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
CHEMBL1641679 59762 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
CHEMBL1739201 59762 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
15675860 202714 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL72147 202714 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
2683 3762 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
5487 3762 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
7308 3762 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
CHEMBL1079 3762 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
DB00697 3762 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
24882007 12352 1 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
CHEMBL1186220 12352 1 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
132111 102508 5 None - 1 Human 4.9 pIC50 = 4.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102508 5 None - 1 Human 4.9 pIC50 = 4.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132111 102508 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102508 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
123132228 155753 46 None -1 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 369 5 1 8 2.4 CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1 10.1021/acs.jmedchem.1c02148
CHEMBL4065484 155753 46 None -1 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 369 5 1 8 2.4 CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1 10.1021/acs.jmedchem.1c02148
11820372 13364 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
CHEMBL1193371 13364 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
CHEMBL544765 13364 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
68602 203406 72 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1021/jm00041a011
CHEMBL77921 203406 72 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1021/jm00041a011
10376336 13077 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL1191106 13077 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL542155 13077 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132111 102508 5 None - 1 Human 5.0 pIC50 = 5.0 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102508 5 None - 1 Human 5.0 pIC50 = 5.0 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132256889 189843 0 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 378 5 1 7 3.6 COc1cccc(F)c1CNc1ccc(-c2cnc(C)nc2C)c2nncn12 10.1021/acs.jmedchem.1c02148
CHEMBL5178464 189843 0 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 378 5 1 7 3.6 COc1cccc(F)c1CNc1ccc(-c2cnc(C)nc2C)c2nncn12 10.1021/acs.jmedchem.1c02148
CHEMBL4755618 212272 35 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at adrenergic receptor alpha2a (unknown origin)Agonist activity at adrenergic receptor alpha2a (unknown origin)
ChEMBL None None None Cc1ncccc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnnc12 10.1021/acs.jmedchem.1c02148
13305910 11716 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11716 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11716 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11716 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
16121006 11721 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11721 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11721 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
499 4002 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4002 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4002 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
6603808 126987 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 126987 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 126987 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 126987 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44417713 12301 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12301 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12301 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44324800 205210 0 None - 0 Human 9.1 pKi = 9.1 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL91157 205210 0 None - 0 Human 9.1 pKi = 9.1 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324972 162808 0 None - 0 Human 8.9 pKi = 8.9 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL419316 162808 0 None - 0 Human 8.9 pKi = 8.9 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44579272 186502 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 186502 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
10758200 63072 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63072 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579184 190349 4 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190349 4 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44579271 186501 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 186501 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579228 181062 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181062 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44404321 69934 0 None - 0 Human 8.4 pKi = 8.4 Functional
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL194323 69934 0 None - 0 Human 8.4 pKi = 8.4 Functional
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44579185 181222 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181222 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
44579230 180952 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 180952 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
44324737 205498 0 None - 0 Human 8.3 pKi = 8.3 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL92860 205498 0 None - 0 Human 8.3 pKi = 8.3 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
44579187 189077 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189077 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
44579229 189014 0 None - 0 Human 7.1 pKi = 7.1 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189014 0 None - 0 Human 7.1 pKi = 7.1 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
2683 3762 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3762 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3762 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3762 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3762 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
1343 1850 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1850 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1850 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1850 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1850 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
2435 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 713 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
521 1372 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1372 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1372 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1372 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1372 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2136 3034 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3034 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3034 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3034 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3034 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
176 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2157 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2566 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
CHEMBL633 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
DB01118 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
1816 2494 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
4205 2494 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
7241 2494 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
CHEMBL654 2494 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
DB00370 2494 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
3952 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1849 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
168295528 192419 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 192419 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 192419 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168294767 192407 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192407 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192407 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
102 4051 44 None -5 50 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
3659 4051 44 None -5 50 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
8969 4051 44 None -5 50 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
CHEMBL15245 4051 44 None -5 50 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
DB01392 4051 44 None -5 50 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
168290235 192356 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192356 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192356 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
164612037 184785 0 None -11 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 184785 0 None -11 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
44377036 119638 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 119638 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376984 55915 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 55915 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376923 56118 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 56118 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
22120332 55739 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 55739 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
1588 2284 24 None 2 44 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2284 24 None 2 44 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2284 24 None 2 44 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2284 24 None 2 44 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2284 24 None 2 44 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
44376954 55436 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 55436 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
22120322 55616 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 55616 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
44377200 57104 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 57104 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
3294 1967 106 None - 45 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
71360 1967 106 None - 45 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
87 1967 106 None - 45 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
CHEMBL14376 1967 106 None - 45 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
DB04946 1967 106 None - 45 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
44376958 57162 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 57162 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
3682 188837 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
CHEMBL1256784 188837 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
CHEMBL513389 188837 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
3045401 55752 28 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 55752 28 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376993 56175 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 56175 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377035 119612 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 119612 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376900 55960 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 55960 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377007 56838 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 56838 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
10531 1387 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1387 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1387 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1387 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1387 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44376927 55333 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 55333 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
9951544 57063 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 57063 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
107715 199250 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 199250 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 199250 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
44376936 57157 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 57157 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10095594 12247 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1185501 12247 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL417550 12247 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10342423 98997 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28312 98997 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL48925 98997 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44401591 68540 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL192266 68540 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
1220 186 46 None - 45 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
31 186 46 None - 45 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
7 186 46 None - 45 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
CHEMBL56 186 46 None - 45 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
10070029 164854 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL423841 164854 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54089 164854 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
59271992 117532 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2A (unknown origin)Inhibition of alpha-adrenoceptor 2A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 117532 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2A (unknown origin)Inhibition of alpha-adrenoceptor 2A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
2477 732 54 None - 29 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
36 732 54 None - 29 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
437 732 54 None - 29 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL49 732 54 None - 29 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
DB00490 732 54 None - 29 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
121852 10056 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10056 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10056 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 95638 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 95638 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 95638 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10040815 96600 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL264027 96600 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26715 96600 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10047322 96679 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL26783 96679 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL50993 96679 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
10364722 98615 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 98615 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 98615 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10338595 161937 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL416747 161937 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10265863 192711 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
CHEMBL52438 192711 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
14450375 164307 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 233 0 1 3 2.3 Cc1ccc(O)c2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
CHEMBL422024 164307 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 233 0 1 3 2.3 Cc1ccc(O)c2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
1305 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
9934033 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL182150 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
2585 788 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 788 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 788 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 788 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 788 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
25208878 180471 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 406 6 1 3 4.9 CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1 10.1021/jm8009469
CHEMBL475969 180471 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 406 6 1 3 4.9 CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1 10.1021/jm8009469
44390778 63933 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 403 5 2 5 4.2 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
CHEMBL180962 63933 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 403 5 2 5 4.2 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
11284878 70083 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194602 70083 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
9885114 119086 3 None -95 12 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119086 3 None -95 12 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL5070958 212468 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21 10.1021/acs.jmedchem.1c01564
4098 32274 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32274 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32274 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
2812 4696 96 None -32 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4696 96 None -32 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
16718919 198089 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 462 4 1 6 4.5 CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1 10.1016/j.bmc.2009.08.006
CHEMBL593889 198089 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 462 4 1 6 4.5 CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1 10.1016/j.bmc.2009.08.006
3561 18871 34 None -1 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 18871 34 None -1 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
23027211 195564 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 421 5 2 5 4.3 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL568400 195564 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 421 5 2 5 4.3 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
11284878 63997 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181217 63997 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44390713 123165 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL362193 123165 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44401626 70995 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195810 70995 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL5076569 212668 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21 10.1021/acs.jmedchem.1c01564
191 399 92 None -41 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 399 92 None -41 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 399 92 None -41 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 399 92 None -41 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 399 92 None -41 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
100 3733 52 None -33 56 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3733 52 None -33 56 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3733 52 None -33 56 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3733 52 None -33 56 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3733 52 None -33 56 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
3158 55959 21 None -3467 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 55959 21 None -3467 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
1343 1850 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1850 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1850 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1850 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1850 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
4735 193435 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 193435 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 193435 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
3584 3706 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3706 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3706 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3706 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3706 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
44401552 165342 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL425012 165342 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
448537 159691 86 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 159691 86 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
2801 161313 56 None -14 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL1200710 161313 56 None -14 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL415 161313 56 None -14 29 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
15730 70759 73 None -2 10 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 70759 73 None -2 10 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
6075 149563 36 None -11 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 149563 36 None -11 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
31101 719 39 None -12 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 719 39 None -12 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 719 39 None -12 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 719 39 None -12 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 719 39 None -12 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
44390730 63971 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 414 5 2 6 3.7 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181099 63971 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 414 5 2 6 3.7 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44390742 122761 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL361442 122761 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14450355 119450 0 None - 0 Bovine 6.8 pIC50 = 6.8 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 259 3 0 3 3.0 CCCN1CCC=C2c3c(OC)cccc3OCC21 10.1021/jm00123a039
CHEMBL349824 119450 0 None - 0 Bovine 6.8 pIC50 = 6.8 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 259 3 0 3 3.0 CCCN1CCC=C2c3c(OC)cccc3OCC21 10.1021/jm00123a039
6726 1249 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
7151 1249 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
749 1249 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL648 1249 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB01176 1249 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
150 2463 18 None -45 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2463 18 None -45 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2463 18 None -45 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2463 18 None -45 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2463 18 None -45 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
23027411 196833 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577912 196833 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
134 2468 19 None -74 68 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2468 19 None -74 68 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2468 19 None -74 68 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2468 19 None -74 68 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2468 19 None -74 68 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
44190762 176296 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of radioligand from adrenergic alpha2A receptorDisplacement of radioligand from adrenergic alpha2A receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 176296 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of radioligand from adrenergic alpha2A receptorDisplacement of radioligand from adrenergic alpha2A receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
2750 202354 69 None -3 12 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 202354 69 None -3 12 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
2351 3222 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3222 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3222 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3222 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3222 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1042 1544 20 None -97 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1544 20 None -97 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1544 20 None -97 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1544 20 None -97 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1544 20 None -97 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
2274 3112 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3112 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3112 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3112 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3112 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44390733 62150 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 537 7 2 6 5.9 CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL178084 62150 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 537 7 2 6 5.9 CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11342160 122407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360671 122407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11342160 122407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL360671 122407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
23027035 196860 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1 10.1016/j.bmcl.2009.09.003
CHEMBL578170 196860 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1 10.1016/j.bmcl.2009.09.003
240 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 929 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
26757 206229 29 None -1 2 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 206229 29 None -1 2 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
196129 67441 12 None -85 15 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67441 12 None -85 15 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
4011 81982 43 None -35 24 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 81982 43 None -35 24 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
26987 934 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 934 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 934 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 934 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 934 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
28417 39784 48 None -1 12 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 39784 48 None -1 12 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
16215415 186739 1 None 3 5 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
CHEMBL493091 186739 1 None 3 5 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
10331436 321 7 None - 7 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
160 321 7 None - 7 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
CHEMBL133455 321 7 None - 7 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
45482789 197237 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
CHEMBL584554 197237 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
1016 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3678 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
3823 49936 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 49936 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 49936 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
2803 939 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
516 939 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
704 939 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
CHEMBL134 939 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
DB00575 939 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
1043 1545 13 None -8 29 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1545 13 None -8 29 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1545 13 None -8 29 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1545 13 None -8 29 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1545 13 None -8 29 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44376975 55680 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 55680 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
121852 10056 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10056 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10056 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
135 2486 38 None -4 58 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
1796 2486 38 None -4 58 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
4184 2486 38 None -4 58 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
CHEMBL6437 2486 38 None -4 58 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
DB06148 2486 38 None -4 58 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
45485061 197066 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL583014 197066 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
44390787 122037 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 443 5 2 5 4.3 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360159 122037 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 443 5 2 5 4.3 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9981024 95638 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 95638 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 95638 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
131001 98523 7 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27995 98523 7 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
10321248 98954 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28287 98954 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50722 98954 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251673 99017 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283207 99017 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52396 99017 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9978353 11134 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL1178987 11134 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL52785 11134 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
10105405 95573 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 5 0 2 3.1 CCCN(CCC)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL25984 95573 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 5 0 2 3.1 CCCN(CCC)C1COc2ccccc2C1 10.1021/jm00038a007
11743327 98236 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27763 98236 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
1577 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
164512405 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
2537 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5355 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5501 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
643497 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
688272 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
958 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
960 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL196677 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL26 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL267044 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB00391 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB16021 3634 104 None -2 26 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
657255 197396 29 None -10 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
CHEMBL588119 197396 29 None -10 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
1210 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
1213 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
2725 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
33036 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
4411 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
616 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
6976 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
716121 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
90475904 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 903 45 None -263 21 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
5467 204202 40 None -6 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
CHEMBL84158 204202 40 None -6 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
14151683 56228 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 2 0 2 2.9 CCCN1CCC=C2c3ccccc3OCC21 10.1021/jm00123a039
CHEMBL163803 56228 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 2 0 2 2.9 CCCN1CCC=C2c3ccccc3OCC21 10.1021/jm00123a039
44401616 69675 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193970 69675 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
45484995 196832 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577904 196832 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
5897 104719 71 None -7 3 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
CHEMBL311469 104719 71 None -7 3 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
1212 1624 45 None -165 66 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1624 45 None -165 66 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1624 45 None -165 66 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1624 45 None -165 66 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1624 45 None -165 66 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
4601 205010 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 205010 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 205010 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
1530 2142 44 None -70 21 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2142 44 None -70 21 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2142 44 None -70 21 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2142 44 None -70 21 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2142 44 None -70 21 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
237 203147 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 203147 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 203147 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 203147 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
124 2921 44 None -4 33 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2921 44 None -4 33 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2921 44 None -4 33 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2921 44 None -4 33 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2921 44 None -4 33 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL5083458 213081 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2 10.1021/acs.jmedchem.1c01564
25014630 83112 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 83112 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
2683 102402 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102402 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102402 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
14151624 55501 0 None - 0 Bovine 6.6 pIC50 = 6.6 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3ccc(O)cc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162282 55501 0 None - 0 Bovine 6.6 pIC50 = 6.6 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3ccc(O)cc3OC[C@H]21 10.1021/jm00123a039
2337 3193 72 None -50 63 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3193 72 None -50 63 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3193 72 None -50 63 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3193 72 None -50 63 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3193 72 None -50 63 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
1305 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
9934033 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
CHEMBL182150 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
4209 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3102 71 None -3235 34 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
2105 2993 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 2993 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 2993 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 2993 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 2993 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
1782 2472 81 None -5 23 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
241 2472 81 None -5 23 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
4168 2472 81 None -5 23 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
CHEMBL86 2472 81 None -5 23 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
DB01233 2472 81 None -5 23 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
3151 1429 93 None -99 27 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1429 93 None -99 27 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1429 93 None -99 27 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1429 93 None -99 27 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1429 93 None -99 27 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
2803 939 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 939 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 939 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 939 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 939 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
42 2024 50 None - 18 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
56971 2024 50 None - 18 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL8412 2024 50 None - 18 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL5077132 212703 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1 10.1021/acs.jmedchem.1c01564
277 1269 55 None -33 46 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1269 55 None -33 46 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1269 55 None -33 46 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1269 55 None -33 46 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1269 55 None -33 46 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
24180125 95199 63 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 469 5 2 8 3.7 O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1 10.1021/jm8012954
CHEMBL257991 95199 63 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 469 5 2 8 3.7 O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1 10.1021/jm8012954
68617 203806 60 None -3 26 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 203806 60 None -3 26 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 203806 60 None -3 26 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
3168 9157 84 None -123 22 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9157 84 None -123 22 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1227 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2331 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
3957 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
4992 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
CHEMBL511 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
DB06691 2444 35 None -91 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2435 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 713 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44376845 55242 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 55242 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
102 4051 44 None -5 50 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
3659 4051 44 None -5 50 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
8969 4051 44 None -5 50 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
CHEMBL15245 4051 44 None -5 50 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
DB01392 4051 44 None -5 50 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
44377006 57146 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165677 57146 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
10014217 99274 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
CHEMBL285010 99274 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
10019102 32289 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 323 3 0 3 3.7 COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1 10.1021/jm010992z
CHEMBL141209 32289 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 323 3 0 3 3.7 COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1 10.1021/jm010992z
44390385 121988 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360117 121988 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
15987265 195202 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL566075 195202 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
10915140 29246 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 351 5 0 3 4.2 COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1 10.1021/jm010992z
CHEMBL138458 29246 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 351 5 0 3 4.2 COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1 10.1021/jm010992z
2335 11728 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11728 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11728 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11728 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
176 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44596863 197239 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
CHEMBL584606 197239 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
2284 3121 27 None -12 29 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3121 27 None -12 29 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3121 27 None -12 29 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3121 27 None -12 29 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3121 27 None -12 29 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
44390369 64264 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181727 64264 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
3038525 13423 107 None -2 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13423 107 None -2 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
44240743 6664 15 None - 1 Human 4.5 pIC50 = 4.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
CHEMBL1083787 6664 15 None - 1 Human 4.5 pIC50 = 4.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
180 397 50 None -58 39 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 397 50 None -58 39 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 397 50 None -58 39 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 397 50 None -58 39 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 397 50 None -58 39 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2726 904 64 None -64 73 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 904 64 None -64 73 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 904 64 None -64 73 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 904 64 None -64 73 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 904 64 None -64 73 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL1350036 67440 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1909062 67440 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
9807658 64200 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181466 64200 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151619 55113 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3c(O)cccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL161947 55113 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3c(O)cccc3OC[C@H]21 10.1021/jm00123a039
2484 206542 64 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
CHEMBL990 206542 64 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
119584 2547 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2547 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2547 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2547 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2547 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
57345320 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
9882 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
CHEMBL3091687 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
57345320 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
9882 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
CHEMBL3091687 3760 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
9904205 204125 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL83658 204125 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
9904205 204125 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL83658 204125 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10219 188200 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188200 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188200 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
5472 204094 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 204094 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 204094 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
2406 99925 84 None -16 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 99925 84 None -16 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
14151652 96179 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 1 3 3.1 CCCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
CHEMBL263574 96179 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 1 3 3.1 CCCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
10231050 63988 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 6 2 6 5.5 CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181184 63988 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 6 2 6 5.5 CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1836 2544 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
3340 2544 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
5281040 2544 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
CHEMBL787 2544 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
DB00471 2544 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
4189 205185 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 205185 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 205185 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
10024943 96927 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26975 96927 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52485 96927 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10429859 11922 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
CHEMBL1183429 11922 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
CHEMBL296395 11922 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
10092409 11926 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1183479 11926 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL299561 11926 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10319624 98517 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27991 98517 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL298534 98517 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
3082597 99085 8 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99085 8 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9975915 99262 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL284912 99262 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10072866 195789 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51561 195789 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL56990 195789 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
5318 15385 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15385 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15385 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
5353853 17788 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17788 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17788 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
3952 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1849 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
135 2486 38 None -4 58 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2486 38 None -4 58 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2486 38 None -4 58 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2486 38 None -4 58 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2486 38 None -4 58 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
10660 14283 55 None -43 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14283 55 None -43 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
6918276 15420 4 None -16 8 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
CHEMBL1221512 15420 4 None -16 8 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
3198 203792 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 203792 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 203792 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
19426635 203871 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL81485 203871 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
44390456 64555 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 9 1 6 6.7 CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.05.121
CHEMBL182235 64555 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 9 1 6 6.7 CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.05.121
1547484 925 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 925 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 925 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 925 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 925 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1441214 39563 0 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1476898 39563 0 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
44390715 123289 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 5.2 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL362400 123289 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 5.2 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11204090 69478 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193771 69478 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
23027527 195107 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL565551 195107 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
10381889 106573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL315772 106573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
10381889 106573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL315772 106573 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
5198 19220 46 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
CHEMBL12948 19220 46 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
2247 502 77 None -58 42 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 502 77 None -58 42 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 502 77 None -58 42 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 502 77 None -58 42 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 502 77 None -58 42 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
3117 206096 100 None -2 16 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206096 100 None -2 16 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
1353 1872 85 None -190 86 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1872 85 None -190 86 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1872 85 None -190 86 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1872 85 None -190 86 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1872 85 None -190 86 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44401671 69908 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194173 69908 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
9980269 98613 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280586 98613 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54266 98613 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251234 11126 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11126 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11126 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10476735 13604 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1195096 13604 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL553833 13604 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10364722 98615 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 98615 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 98615 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44318454 204280 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL84931 204280 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
14450361 55766 0 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 275 3 0 3 3.4 CCCN1CCC[C@@H]2c3c(OC)cc(C)cc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162510 55766 0 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 275 3 0 3 3.4 CCCN1CCC[C@@H]2c3c(OC)cc(C)cc3OC[C@H]21 10.1021/jm00123a039
44390752 122467 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 523 6 1 6 5.4 CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360876 122467 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 523 6 1 6 5.4 CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL508338 188369 0 None -6 6 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
11057 175565 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 175565 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 175565 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 175565 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
135398745 2858 108 None -93 66 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2858 108 None -93 66 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2858 108 None -93 66 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2858 108 None -93 66 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
1201549 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
3598 187228 73 None -2 7 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
CHEMBL496 187228 73 None -2 7 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
10243700 55975 1 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cc(O)ccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162955 55975 1 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cc(O)ccc3OC[C@H]21 10.1021/jm00123a039
11204090 63162 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL180003 63162 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44401449 70735 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195346 70735 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
10303307 64130 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181393 64130 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1549008 203957 81 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
CHEMBL822 203957 81 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
2520 202301 65 None -6 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 202301 65 None -6 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 202301 65 None -6 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
133 2450 48 None -23 43 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2450 48 None -23 43 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2450 48 None -23 43 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2450 48 None -23 43 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2450 48 None -23 43 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
44401508 69463 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
CHEMBL193666 69463 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
45485062 195482 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
CHEMBL567993 195482 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
12488 1619 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1619 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1619 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1619 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL1200633 206848 3 None -7 8 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O nan
145949343 162370 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 404 6 2 4 3.9 c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2 10.1021/acsmedchemlett.8b00030
CHEMBL4174290 162370 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 404 6 2 4 3.9 c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2 10.1021/acsmedchemlett.8b00030
2142 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3035 54 None -2 37 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
102 4051 44 None -5 50 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4051 44 None -5 50 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4051 44 None -5 50 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4051 44 None -5 50 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4051 44 None -5 50 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
73453 29388 22 None -3 17 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29388 22 None -3 17 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
44390710 64243 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 4.9 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181632 64243 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 4.9 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
10252000 98082 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27650 98082 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50188 98082 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
2162 41258 97 None 1 6 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL1491 41258 97 None 1 6 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL5082142 213005 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None c1cnc2c(c1)CN[C@@H](CN(CCCCN1CCOCC1)[C@H]1CCCc3cccnc31)C2 10.1021/acs.jmedchem.1c01564
10357986 29676 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 309 3 0 3 3.9 COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21 10.1021/jm010992z
CHEMBL138809 29676 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 309 3 0 3 3.9 COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21 10.1021/jm010992z
11080 28857 74 None 1 6 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL1381098 28857 74 None 1 6 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
44390706 121506 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 467 5 2 5 4.6 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL359510 121506 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 467 5 2 5 4.6 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151702 56037 1 None - 0 Bovine 6.2 pIC50 = 6.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 245 2 1 3 2.7 CCCN1CCC=C2c3cc(O)ccc3OCC21 10.1021/jm00123a039
CHEMBL163061 56037 1 None - 0 Bovine 6.2 pIC50 = 6.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 245 2 1 3 2.7 CCCN1CCC=C2c3cc(O)ccc3OCC21 10.1021/jm00123a039
6761 67442 17 None -6 18 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67442 17 None -6 18 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
1752 45489 56 None -2 5 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
CHEMBL153062 45489 56 None -2 5 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
2286 3122 48 None -13 30 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3122 48 None -13 30 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3122 48 None -13 30 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3122 48 None -13 30 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3122 48 None -13 30 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL1458880 37602 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
9895868 12775 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL1188966 12775 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL537846 12775 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9895868 69224 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193438 69224 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
134551 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
16718917 181090 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 412 6 1 4 5.0 CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1 10.1021/jm8009469
CHEMBL477650 181090 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 412 6 1 4 5.0 CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1 10.1021/jm8009469
168281847 190432 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Displacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assay
ChEMBL 310 3 1 4 3.6 COc1ccc(/C=C2\CCc3c(O)cccc3C2=O)cc1OC 10.1016/j.ejmech.2021.113964
CHEMBL5187030 190432 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Displacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assay
ChEMBL 310 3 1 4 3.6 COc1ccc(/C=C2\CCc3c(O)cccc3C2=O)cc1OC 10.1016/j.ejmech.2021.113964
14151613 56181 0 None - 0 Bovine 7.2 pIC50 = 7.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 0 3 3.0 CCCN1CCC[C@@H]2c3c(OC)cccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL163281 56181 0 None - 0 Bovine 7.2 pIC50 = 7.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 0 3 3.0 CCCN1CCC[C@@H]2c3c(OC)cccc3OC[C@H]21 10.1021/jm00123a039
44390726 121876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 449 7 2 7 3.9 COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
CHEMBL360081 121876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 449 7 2 7 3.9 COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
23027245 195442 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL567791 195442 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
4543 169972 36 None -8 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL1201156 169972 36 None -8 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL445 169972 36 None -8 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
4211 57502 81 None -1 4 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
CHEMBL1670 57502 81 None -1 4 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
1028 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 287 69 None -30 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
44390750 63133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 423 5 2 5 4.5 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL179878 63133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 423 5 2 5 4.5 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151647 55359 1 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
CHEMBL162170 55359 1 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
3082597 99085 8 None - 1 Bovine 6.1 pIC50 = 6.1 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99085 8 None - 1 Bovine 6.1 pIC50 = 6.1 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
12575 1949 28 None -5 17 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 1949 28 None -5 17 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 1949 28 None -5 17 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
102 4051 44 None -5 50 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
3659 4051 44 None -5 50 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
8969 4051 44 None -5 50 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
CHEMBL15245 4051 44 None -5 50 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
DB01392 4051 44 None -5 50 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
118112300 155441 12 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at alpha2A-adrenergic receptor (unknown origin)Antagonist activity at alpha2A-adrenergic receptor (unknown origin)
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
CHEMBL4061793 155441 12 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at alpha2A-adrenergic receptor (unknown origin)Antagonist activity at alpha2A-adrenergic receptor (unknown origin)
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
CHEMBL5093818 213660 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.1c01564
3191 102372 93 None -8 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102372 93 None -8 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
1816 2494 99 None -33 17 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 2494 99 None -33 17 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 2494 99 None -33 17 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 2494 99 None -33 17 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 2494 99 None -33 17 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
44401460 70548 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL195123 70548 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
14151595 56202 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 231 2 0 2 3.0 CCCN1CCC[C@@H]2c3ccccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL163532 56202 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 231 2 0 2 3.0 CCCN1CCC[C@@H]2c3ccccc3OC[C@H]21 10.1021/jm00123a039
70788951 26933 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1366 26933 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
46227396 199945 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 420 4 2 6 3.4 O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12 10.1016/j.bmc.2009.08.006
CHEMBL605938 199945 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 420 4 2 6 3.4 O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12 10.1016/j.bmc.2009.08.006
42636941 178361 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 178361 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
8447 188352 80 None -4 13 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188352 80 None -4 13 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
2389 3267 114 None -87 68 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3267 114 None -87 68 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3267 114 None -87 68 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3267 114 None -87 68 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3267 114 None -87 68 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44390499 129122 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL367355 129122 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
135398737 942 89 None -26 92 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 942 89 None -26 92 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 942 89 None -26 92 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 942 89 None -26 92 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 942 89 None -26 92 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
213 3780 50 None -10 44 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3780 50 None -10 44 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3780 50 None -10 44 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3780 50 None -10 44 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3780 50 None -10 44 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
3082597 99085 8 None - 1 Bovine 5.0 pIC50 = 5.0 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99085 8 None - 1 Bovine 5.0 pIC50 = 5.0 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
36324 26901 71 None - 1 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
CHEMBL1365675 26901 71 None - 1 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
1548953 205935 24 None -1 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 205935 24 None -1 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
14450364 55697 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 1 0 3 2.6 COc1cc(C)cc2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
CHEMBL162449 55697 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 1 0 3 2.6 COc1cc(C)cc2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
44390768 64128 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 434 6 2 7 3.8 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181383 64128 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 434 6 2 7 3.8 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1562 884 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
5312114 884 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL17645 884 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL195380 884 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
441383 20118 54 None -2 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20118 54 None -2 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
164612037 184785 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 184785 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 192356 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192356 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192356 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 192407 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192407 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192407 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 192419 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 192419 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 192419 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
118714540 114000 0 None 5 4 Human 9.0 pKd = 9.0 Binding
Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 minsDisplacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins
ChEMBL 677 13 6 15 1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/ml5002486
CHEMBL3335523 114000 0 None 5 4 Human 9.0 pKd = 9.0 Binding
Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 minsDisplacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins
ChEMBL 677 13 6 15 1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/ml5002486
10220232 99247 5 None 54 6 Rat 11.1 pKi = 11.1 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
CHEMBL284795 99247 5 None 54 6 Rat 11.1 pKi = 11.1 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
521 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
5311068 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
835 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
CHEMBL778 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
DB00633 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
521 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
5311068 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
835 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
CHEMBL778 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
DB00633 1372 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
49781228 17008 1 None 2 4 Human 10.6 pKi = 10.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17008 1 None 2 4 Human 10.6 pKi = 10.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
155540329 171898 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 426 7 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4482861 171898 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 426 7 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
78114674 173144 0 None - 1 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 380 7 0 7 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4536304 173144 0 None - 1 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 380 7 0 7 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
155513359 169185 0 None - 1 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 471 8 0 8 3.9 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4438801 169185 0 None - 1 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 471 8 0 8 3.9 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
49781228 17008 1 None 2 4 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17008 1 None 2 4 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
49781228 17008 1 None 2 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17008 1 None 2 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
11271808 60654 0 None 1 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 490 9 0 7 3.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL176261 60654 0 None 1 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 490 9 0 7 3.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
11306100 167931 0 None -3 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 477 9 0 7 3.5 COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL435352 167931 0 None -3 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 477 9 0 7 3.5 COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
1588 2284 24 None 2 44 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2284 24 None 2 44 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2284 24 None 2 44 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2284 24 None 2 44 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2284 24 None 2 44 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
52944548 16956 0 None 1 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255723 16956 0 None 1 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
52941512 17001 0 None 1 4 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256378 17001 0 None 1 4 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
135519400 63548 0 None -1 2 Human 9.7 pKi = 9.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 419 5 1 6 3.2 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL180470 63548 0 None -1 2 Human 9.7 pKi = 9.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 419 5 1 6 3.2 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1 10.1021/jm049619s
49781222 17054 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256609 17054 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
46224879 199852 3 None -1 7 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL605405 199852 3 None -1 7 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
124 2921 44 None -4 33 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
2032 2921 44 None -4 33 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
4636 2921 44 None -4 33 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
CHEMBL762 2921 44 None -4 33 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
DB00935 2921 44 None -4 33 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
44330168 4239 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL100879 4239 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
11225779 107233 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319119 107233 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324972 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419316 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324972 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324800 205210 0 None -5 7 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 205210 0 None -5 7 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324972 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL419316 162808 0 None -2 4 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324800 205210 0 None -5 7 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL91157 205210 0 None -5 7 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
78114597 171907 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 356 6 0 6 2.6 CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4483022 171907 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 356 6 0 6 2.6 CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
49781887 16948 0 None 3 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16948 0 None 3 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
9837136 99463 2 None - 1 Rat 9.5 pKi = 9.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm990569e
CHEMBL286269 99463 2 None - 1 Rat 9.5 pKi = 9.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm990569e
9837136 99463 2 None - 1 Rat 9.5 pKi = 9.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm000128r
CHEMBL286269 99463 2 None - 1 Rat 9.5 pKi = 9.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm000128r
108094 3356 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
526 3356 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
528 3356 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
CHEMBL10332 3356 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
10531 1387 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1387 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1387 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1387 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1387 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
10056237 13617 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195197 13617 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL554019 13617 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
2803 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
516 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
704 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
CHEMBL134 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
DB00575 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
2803 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
516 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
704 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL134 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
DB00575 939 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
11259744 60457 0 None -1 2 Human 9.4 pKi = 9.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 461 6 0 7 3.4 CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL176116 60457 0 None -1 2 Human 9.4 pKi = 9.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 461 6 0 7 3.4 CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
52948958 16957 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255724 16957 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
102 4051 44 None -5 50 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
3659 4051 44 None -5 50 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
8969 4051 44 None -5 50 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
CHEMBL15245 4051 44 None -5 50 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
DB01392 4051 44 None -5 50 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
52943739 16963 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
CHEMBL1255771 16963 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
44387789 60236 0 None -2 2 Human 9.3 pKi = 9.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 433 6 0 6 3.5 COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL176002 60236 0 None -2 2 Human 9.3 pKi = 9.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 433 6 0 6 3.5 COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
44330114 107583 0 None -1 2 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319530 107583 0 None -1 2 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324906 205050 0 None 3 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90247 205050 0 None 3 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
49781223 17055 0 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256610 17055 0 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
9815633 99161 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
CHEMBL284213 99161 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
9815633 99161 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
CHEMBL284213 99161 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
49781005 17017 0 None 3 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17017 0 None 3 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
49781887 16948 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16948 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
11214030 60205 0 None -3 2 Human 9.2 pKi = 9.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 491 8 0 8 3.1 COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL175853 60205 0 None -3 2 Human 9.2 pKi = 9.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 491 8 0 8 3.1 COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
107715 199250 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 199250 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 199250 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
11765813 12854 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189483 12854 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL538808 12854 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
13938361 184771 0 None 141 2 Bovine 9.1 pKi = 9.1 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48603 184771 0 None 141 2 Bovine 9.1 pKi = 9.1 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
1043 1545 13 None -8 29 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1545 13 None -8 29 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1545 13 None -8 29 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1545 13 None -8 29 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1545 13 None -8 29 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44324800 205210 0 None -5 7 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL91157 205210 0 None -5 7 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324887 164452 0 None 2 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL422597 164452 0 None 2 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44325050 205540 0 None -3 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93171 205540 0 None -3 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44126269 199789 4 None -2 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
CHEMBL605081 199789 4 None -2 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
49781224 16947 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255616 16947 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
12114852 13194 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1192051 13194 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL543232 13194 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
11785068 60217 0 None -2 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 7 3.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL175911 60217 0 None -2 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 7 3.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
11260018 63513 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 473 7 0 7 3.6 C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL180322 63513 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 473 7 0 7 3.6 C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
71450907 78514 0 None 1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL2112978 78514 0 None 1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1 10.1021/jm049619s
44324937 205176 0 None 1 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90943 205176 0 None 1 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
2142 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
4920903 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
502 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
5775 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
CHEMBL597 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
DB00692 3035 54 None 1 37 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
155547631 173112 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 432 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4535472 173112 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 432 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11318438 165420 0 None -1 2 Human 9.0 pKi = 9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 524 7 0 8 4.1 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL425324 165420 0 None -1 2 Human 9.0 pKi = 9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 524 7 0 8 4.1 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1 10.1021/jm049619s
9805944 55919 31 None -1 9 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from adrenergic alpha2A receptorDisplacement of [125I]HEAT from adrenergic alpha2A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 55919 31 None -1 9 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from adrenergic alpha2A receptorDisplacement of [125I]HEAT from adrenergic alpha2A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
44330635 206674 0 None -2 2 Human 9.0 pKi = 9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1 10.1016/j.bmcl.2004.03.031
CHEMBL99868 206674 0 None -2 2 Human 9.0 pKi = 9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1 10.1016/j.bmcl.2004.03.031
52950140 16962 0 None 1 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255770 16962 0 None 1 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
44330668 4355 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101596 4355 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330617 96159 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL263424 96159 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44371848 13499 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1194334 13499 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL551711 13499 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
9837551 101140 0 None 7 3 Human 8.9 pKi = 8.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
CHEMBL298936 101140 0 None 7 3 Human 8.9 pKi = 8.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
12114853 12903 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189875 12903 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539606 12903 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
10847653 57129 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 240 0 1 2 2.6 C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1 10.1021/jm001040g
CHEMBL165529 57129 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 240 0 1 2 2.6 C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1 10.1021/jm001040g
11785961 62935 0 None -6 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 535 13 0 8 4.0 CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL179237 62935 0 None -6 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 535 13 0 8 4.0 CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
11190988 131268 0 None -2 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 6 4.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL369378 131268 0 None -2 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 6 4.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
136019934 143985 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143985 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
44324737 205498 0 None -2 5 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 205498 0 None -2 5 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324737 205498 0 None -2 5 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL92860 205498 0 None -2 5 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
10123375 13124 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191431 13124 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542527 13124 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
13938356 184485 0 None 154 2 Bovine 8.9 pKi = 8.9 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48558 184485 0 None 154 2 Bovine 8.9 pKi = 8.9 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
44330369 111080 0 None -4 2 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328195 111080 0 None -4 2 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
102 4051 44 None -5 50 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
3659 4051 44 None -5 50 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
8969 4051 44 None -5 50 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
CHEMBL15245 4051 44 None -5 50 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
DB01392 4051 44 None -5 50 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
44325049 111022 0 None -2 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL327875 111022 0 None -2 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
10707358 178695 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL47313 178695 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
12575 1949 28 None 1 17 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
54459 1949 28 None 1 17 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
CHEMBL10316 1949 28 None 1 17 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
9815610 99458 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
CHEMBL286246 99458 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
124 2921 44 None -5 33 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
2032 2921 44 None -5 33 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
4636 2921 44 None -5 33 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
CHEMBL762 2921 44 None -5 33 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
DB00935 2921 44 None -5 33 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
9815610 99458 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
CHEMBL286246 99458 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
11200476 78506 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for Alpha-2A adrenergic receptorBinding affinity for Alpha-2A adrenergic receptor
ChEMBL 402 5 0 5 3.2 CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112970 78506 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for Alpha-2A adrenergic receptorBinding affinity for Alpha-2A adrenergic receptor
ChEMBL 402 5 0 5 3.2 CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
9837600 23102 0 None 12 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
CHEMBL133231 23102 0 None 12 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
46891598 7082 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rauwolscine from adrenergic alpha2A receptorDisplacement of [3H]rauwolscine from adrenergic alpha2A receptor
ChEMBL 402 5 0 5 3.2 CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2010.04.099
CHEMBL1085510 7082 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rauwolscine from adrenergic alpha2A receptorDisplacement of [3H]rauwolscine from adrenergic alpha2A receptor
ChEMBL 402 5 0 5 3.2 CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2010.04.099
42266865 15412 2 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 389 6 1 4 3.4 COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221498 15412 2 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 389 6 1 4 3.4 COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
2142 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
4920903 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
502 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
5775 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
CHEMBL597 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
DB00692 3035 54 None -2 37 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
10176999 103066 14 None 11 3 Human 8.8 pKi = 8.8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103066 14 None 11 3 Human 8.8 pKi = 8.8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
44330653 206481 0 None -8 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98646 206481 0 None -8 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330645 206682 0 None -3 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL99916 206682 0 None -3 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10350094 13690 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195716 13690 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL555190 13690 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
49781005 17017 0 None 3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17017 0 None 3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
13123525 188599 0 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
CHEMBL51131 188599 0 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
13123534 188853 1 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
CHEMBL51358 188853 1 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
71461647 78508 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 439 5 0 5 4.4 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
CHEMBL2112972 78508 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 439 5 0 5 4.4 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
71456240 78517 0 None 2 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 415 6 0 5 3.8 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL2112982 78517 0 None 2 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 415 6 0 5 3.8 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1 10.1021/jm049619s
102 4051 44 None -5 50 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
3659 4051 44 None -5 50 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
8969 4051 44 None -5 50 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
CHEMBL15245 4051 44 None -5 50 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
DB01392 4051 44 None -5 50 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
12576 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
71310 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
CHEMBL353972 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
DB11481 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
44330368 111687 0 None -3 2 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 479 7 1 8 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL329065 111687 0 None -3 2 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 479 7 1 8 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
108094 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
526 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
528 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
CHEMBL10332 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
42631003 197927 10 None -10 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL592752 197927 10 None -10 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
10198135 203405 3 None 43 3 Human 8.0 pKi = 8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
CHEMBL77913 203405 3 None 43 3 Human 8.0 pKi = 8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
2389 3267 114 None -87 68 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
5073 3267 114 None -87 68 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
96 3267 114 None -87 68 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
CHEMBL85 3267 114 None -87 68 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
DB00734 3267 114 None -87 68 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
44401243 167918 0 None -4 9 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL435301 167918 0 None -4 9 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
49836302 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276139 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
10176715 156580 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 2 2.4 C1=NCC(CC2=Cc3ccccc3CC2)N1 10.1021/jm001040g
CHEMBL407509 156580 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 2 2.4 C1=NCC(CC2=Cc3ccccc3CC2)N1 10.1021/jm001040g
242 467 117 None -26 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 467 117 None -26 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 467 117 None -26 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 467 117 None -26 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 467 117 None -26 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
250 3322 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 3322 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 3322 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
135398737 942 89 None -10 92 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
38 942 89 None -10 92 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
722 942 89 None -10 92 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
CHEMBL42 942 89 None -10 92 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
DB00363 942 89 None -10 92 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
49836302 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276139 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
49836302 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276139 18364 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
13938357 101247 0 None 79 2 Bovine 7.0 pKi = 7 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL299595 101247 0 None 79 2 Bovine 7.0 pKi = 7 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
135398737 942 89 None -26 92 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 942 89 None -26 92 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 942 89 None -26 92 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 942 89 None -26 92 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 942 89 None -26 92 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
135398745 2858 108 None -93 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 2858 108 None -93 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 2858 108 None -93 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 2858 108 None -93 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
2389 3267 114 None -87 68 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 3267 114 None -87 68 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 3267 114 None -87 68 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 3267 114 None -87 68 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 3267 114 None -87 68 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
90644728 112242 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289543 112242 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3305161 112242 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
16090600 168604 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
CHEMBL440594 168604 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
10324985 76413 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL199824 76413 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL2068762 76413 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
127035062 135915 0 None -3 19 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 135915 0 None -3 19 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
10443343 18299 1 None - 1 Bovine 6.0 pKi = 6.0 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 0 5 0.5 CN1CCN(c2nccn3ccnc23)CC1 10.1021/jm00099a012
CHEMBL127303 18299 1 None - 1 Bovine 6.0 pKi = 6.0 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 0 5 0.5 CN1CCN(c2nccn3ccnc23)CC1 10.1021/jm00099a012
1782 2472 81 None -5 23 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
241 2472 81 None -5 23 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
4168 2472 81 None -5 23 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
CHEMBL86 2472 81 None -5 23 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
DB01233 2472 81 None -5 23 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
44574076 171884 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448147 171884 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
9960497 116561 0 None -309 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 116561 0 None -309 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
57395731 70831 0 None 6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 70831 0 None 6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
44312037 202903 1 None 1 6 Human 5.0 pKi = 5.0 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 202903 1 None 1 6 Human 5.0 pKi = 5.0 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
3151 1429 93 None -99 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1429 93 None -99 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1429 93 None -99 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1429 93 None -99 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1429 93 None -99 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
12909387 62293 0 None -33 2 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL178376 62293 0 None -33 2 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
9904117 9297 3 None 1 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 9297 3 None 1 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11091738 117576 0 None -1584 6 Rat 6.0 pKi = 6.0 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
CHEMBL340641 117576 0 None -1584 6 Rat 6.0 pKi = 6.0 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
57402718 70830 2 None 1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 70830 2 None 1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
2803 939 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 939 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 939 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 939 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 939 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
16090624 81975 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL217278 81975 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
4209 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3102 71 None -173 34 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
277 1269 55 None -33 46 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1269 55 None -33 46 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1269 55 None -33 46 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1269 55 None -33 46 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1269 55 None -33 46 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
1268096 15974 21 None -3 4 Human 7.0 pKi = 7.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL122404 15974 21 None -3 4 Human 7.0 pKi = 7.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
90644708 112232 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289530 112232 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304993 112232 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
68617 203806 60 None -3 26 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 203806 60 None -3 26 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 203806 60 None -3 26 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
10769331 111032 0 None -208 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 111032 0 None -208 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
197033 197463 58 None -13 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL589390 197463 58 None -13 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
13298529 100736 50 None 134 2 Bovine 8.0 pKi = 8.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295921 100736 50 None 134 2 Bovine 8.0 pKi = 8.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
71456238 78513 0 None -2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 504 9 0 7 4.4 COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL2112977 78513 0 None -2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 504 9 0 7 4.4 COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
46934426 15434 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 431 9 1 4 4.6 COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221591 15434 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 431 9 1 4 4.6 COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
49781004 17016 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256502 17016 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
44371755 48498 0 None 15 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48498 0 None 15 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
90469115 185250 2 None -36 17 Human 7.0 pKi = 7.0 Binding
Binding affinity to human adrenergic alpha 2A receptorBinding affinity to human adrenergic alpha 2A receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4867565 185250 2 None -36 17 Human 7.0 pKi = 7.0 Binding
Binding affinity to human adrenergic alpha 2A receptorBinding affinity to human adrenergic alpha 2A receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
9809007 171986 6 None -1905 6 Human 6.0 pKi = 6.0 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 171986 6 None -1905 6 Human 6.0 pKi = 6.0 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
10109188 165511 0 None -43 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 4 1 4 4.6 CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL425803 165511 0 None -43 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 4 1 4 4.6 CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
44574103 172009 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448908 172009 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
162661022 180856 0 None - 1 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4764318 180856 0 None - 1 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
3168 9157 84 None -123 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9157 84 None -123 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1227 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2331 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
3957 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
4992 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
CHEMBL511 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
DB06691 2444 35 None -91 12 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2435 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 713 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44574079 188710 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL512289 188710 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
10531766 205259 0 None -999 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 205259 0 None -999 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
62381476 112257 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289536 112257 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305461 112257 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
122295 9760 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
CHEMBL114166 9760 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
122295 9760 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 9760 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
44574104 188889 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513871 188889 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
145990586 166279 0 None -89 11 Human 5.9 pKi = 5.9 Binding
Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 166279 0 None -89 11 Human 5.9 pKi = 5.9 Binding
Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
2335 11728 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11728 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11728 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11728 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
176 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44424855 85015 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85015 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44325038 205179 0 None -3 3 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90966 205179 0 None -3 3 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
127026052 137015 0 None -7 19 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 137015 0 None -7 19 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
16090630 82810 0 None -309 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
CHEMBL218675 82810 0 None -309 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
10579368 105511 0 None -5 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 105511 0 None -5 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
155526524 170609 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 364 6 0 6 2.4 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4459090 170609 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 364 6 0 6 2.4 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644720 112248 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289524 112248 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305319 112248 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
44579230 180952 0 None -50 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 180952 0 None -50 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
10316512 16673 2 None -18 2 Bovine 4.9 pKi = 4.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
CHEMBL124926 16673 2 None -18 2 Bovine 4.9 pKi = 4.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
10081626 20880 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131220 20880 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
10262765 116042 0 None 13 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336332 116042 0 None 13 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
398712 77501 5 None -12 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cellsDisplacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cells
ChEMBL 417 9 1 5 2.9 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1 10.1021/jm0508641
CHEMBL209324 77501 5 None -12 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cellsDisplacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cells
ChEMBL 417 9 1 5 2.9 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1 10.1021/jm0508641
44325075 111260 0 None -2 2 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 465 8 0 8 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328735 111260 0 None -2 2 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 465 8 0 8 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44292196 179416 0 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
CHEMBL47471 179416 0 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
9809007 171986 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 171986 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
2775690 92565 47 None -45 6 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenoceptor receptor (unknown origin)Binding affinity to alpha2A adrenoceptor receptor (unknown origin)
ChEMBL 295 1 1 3 3.0 Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1 10.1021/ml400312j
CHEMBL2441619 92565 47 None -45 6 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenoceptor receptor (unknown origin)Binding affinity to alpha2A adrenoceptor receptor (unknown origin)
ChEMBL 295 1 1 3 3.0 Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1 10.1021/ml400312j
9809007 171986 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 171986 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
11380132 83984 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
CHEMBL221989 83984 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
1268096 15974 21 None -42 4 Rat 5.9 pKi = 5.9 Binding
Compound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptorCompound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL122404 15974 21 None -42 4 Rat 5.9 pKi = 5.9 Binding
Compound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptorCompound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
92766 106047 30 None -12 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 106047 30 None -12 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
24839550 136778 14 None -1 15 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 136778 14 None -1 15 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
11246610 83881 0 None 2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL221523 83881 0 None 2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
16090626 81709 0 None -77 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL216727 81709 0 None -77 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
44421258 84308 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84308 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84308 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
90644730 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289544 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305465 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
71452341 83269 4 None -4 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 376 6 0 3 5.3 Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12 10.1016/j.bmc.2012.09.044
CHEMBL2205361 83269 4 None -4 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 376 6 0 3 5.3 Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12 10.1016/j.bmc.2012.09.044
44269006 32122 1 None -1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL14107 32122 1 None -1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
24906243 186655 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
CHEMBL492648 186655 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
1267 3732 43 None -52 28 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
3035905 3732 43 None -52 28 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
CHEMBL260374 3732 43 None -52 28 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
2284 3121 27 None -12 29 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3121 27 None -12 29 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3121 27 None -12 29 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3121 27 None -12 29 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3121 27 None -12 29 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
9839050 111873 0 None -263 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 293 2 0 2 3.8 CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1 10.1021/jm049632c
CHEMBL329566 111873 0 None -263 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 293 2 0 2 3.8 CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1 10.1021/jm049632c
9928335 119579 1 None -3 6 Rat 6.9 pKi = 6.9 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL35093 119579 1 None -3 6 Rat 6.9 pKi = 6.9 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL4520788 212215 6 None -6 25 Human 6.9 pKi = 6.9 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2A
ChEMBL None None None CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1 nan
3038525 13423 107 None -2 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13423 107 None -2 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
181743 177987 3 None -645 22 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2A receptorDisplacement of [3H]Clonidine from human adrenergic alpha2A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 177987 3 None -645 22 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2A receptorDisplacement of [3H]Clonidine from human adrenergic alpha2A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
9827677 167847 0 None -6456 7 Human 5.9 pKi = 5.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 167847 0 None -6456 7 Human 5.9 pKi = 5.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
10627021 106598 0 None -933 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 106598 0 None -933 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
129211 3680 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3680 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3680 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3680 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3680 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
44292385 100639 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL295186 100639 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
10609673 103287 0 None 11 3 Human 6.9 pKi = 6.9 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
CHEMBL308863 103287 0 None 11 3 Human 6.9 pKi = 6.9 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
CHEMBL179334 62958 0 None -7079 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
162664874 181584 0 None - 1 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 519 9 5 11 1.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4782649 181584 0 None - 1 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 519 9 5 11 1.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
71450550 83379 0 None -2 16 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenergic receptorBinding affinity to alpha2A adrenergic receptor
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
CHEMBL2205836 83379 0 None -2 16 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenergic receptorBinding affinity to alpha2A adrenergic receptor
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
9926529 9284 2 None -1 5 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 9284 2 None -1 5 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10221004 202521 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 202521 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
90644736 112262 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289547 112262 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305466 112262 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
180 397 50 None -58 39 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 397 50 None -58 39 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 397 50 None -58 39 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 397 50 None -58 39 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 397 50 None -58 39 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2726 904 64 None -64 73 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 904 64 None -64 73 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 904 64 None -64 73 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 904 64 None -64 73 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 904 64 None -64 73 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
10475736 165299 0 None -26 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL424917 165299 0 None -26 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
3805301 100854 76 None -1 2 Bovine 5.9 pKi = 5.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL296787 100854 76 None -1 2 Bovine 5.9 pKi = 5.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL1350036 67440 0 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1909062 67440 0 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
44438148 93044 0 None -14 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246229 93044 0 None -14 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
11779308 18302 8 None 4 2 Bovine 5.9 pKi = 5.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
CHEMBL127318 18302 8 None 4 2 Bovine 5.9 pKi = 5.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
44288877 168023 0 None -1905 5 Human 4.9 pKi = 4.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 168023 0 None -1905 5 Human 4.9 pKi = 4.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
2484 206542 64 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
CHEMBL990 206542 64 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
599482 201286 9 None -9 6 Human 5.9 pKi = 5.9 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
CHEMBL6310 201286 9 None -9 6 Human 5.9 pKi = 5.9 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
119584 2547 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2547 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2547 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2547 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2547 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
44579228 181062 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181062 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
11265631 135873 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 135873 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
11265631 135873 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135873 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
10317643 98075 0 None -32 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL276417 98075 0 None -32 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
2737203 183332 76 None 141 2 Bovine 7.9 pKi = 7.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48137 183332 76 None 141 2 Bovine 7.9 pKi = 7.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
13123527 101307 3 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300053 101307 3 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
13123531 187648 0 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
CHEMBL49953 187648 0 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
10219 188200 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188200 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188200 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
11211035 84565 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL223836 84565 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
11211035 84565 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL223836 84565 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
10376053 13009 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL1190547 13009 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL541088 13009 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
16090622 81872 0 None -165 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
CHEMBL217202 81872 0 None -165 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
10070896 82769 0 None -281 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
CHEMBL218457 82769 0 None -281 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
44438166 93371 0 None -33 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247664 93371 0 None -33 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
4428003 112254 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289540 112254 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305332 112254 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
155566429 175344 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 378 7 0 6 2.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4587519 175344 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 378 7 0 6 2.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644758 112241 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289541 112241 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305160 112241 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
5472 204094 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 204094 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 204094 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
10318507 58630 0 None -173 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL1689423 58630 0 None -173 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
2406 99925 84 None -16 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 99925 84 None -16 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
43260 5393 61 None 1 5 Human 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 5393 61 None 1 5 Human 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
10758200 63072 0 None -43 5 Human 6.8 pKi = 6.8 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63072 0 None -43 5 Human 6.8 pKi = 6.8 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
1836 2544 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
3340 2544 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
5281040 2544 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
CHEMBL787 2544 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
DB00471 2544 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
44574135 188579 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL511211 188579 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
90644702 112206 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289533 112206 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304532 112206 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
44311789 203018 0 None -1 5 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 203018 0 None -1 5 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
9894818 98455 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 98455 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
4189 205185 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 205185 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 205185 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
131268 112390 24 None 26 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL331036 112390 24 None 26 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
3952 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1849 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
10266032 188284 0 None 2 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50720 188284 0 None 2 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
12114851 12916 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189965 12916 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539824 12916 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
44292386 100999 0 None 5 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297827 100999 0 None 5 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
13123529 101380 0 None - 1 Bovine 6.8 pKi = 6.8 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300628 101380 0 None - 1 Bovine 6.8 pKi = 6.8 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
12574 2557 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
4810 2557 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
CHEMBL19236 2557 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
DB09242 2557 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
3584 3706 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3706 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3706 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3706 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3706 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
11041026 179635 43 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 162 1 2 2 0.7 NCC1Cc2ccccc2CN1 10.1021/acs.jmedchem.0c01475
CHEMBL4749860 179635 43 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 162 1 2 2 0.7 NCC1Cc2ccccc2CN1 10.1021/acs.jmedchem.0c01475
162645059 178824 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4740168 178824 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
162653032 179800 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 505 8 5 11 0.7 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4751862 179800 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 505 8 5 11 0.7 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
162654934 179999 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4754362 179999 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
9894818 98455 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98455 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10474335 193015 16 None -52 10 Human 5.8 pKi = 5.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
CHEMBL53325 193015 16 None -52 10 Human 5.8 pKi = 5.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
90644710 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289529 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3304670 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
44421258 84308 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84308 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84308 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
62379598 112259 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289539 112259 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305463 112259 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
5318 15385 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15385 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15385 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
5353853 17788 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17788 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17788 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
101333429 116562 0 None -3890 6 Human 5.8 pKi = 5.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 116562 0 None -3890 6 Human 5.8 pKi = 5.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
11186523 126976 0 None -109 9 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL366164 126976 0 None -109 9 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
135356876 173492 0 None -9 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assayBinding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay
ChEMBL 464 5 2 6 5.5 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1 10.1021/acs.jmedchem.6b00044
CHEMBL4544251 173492 0 None -9 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assayBinding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay
ChEMBL 464 5 2 6 5.5 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1 10.1021/acs.jmedchem.6b00044
114697 3618 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
513 3618 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
CHEMBL101340 3618 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
12981869 168060 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL436234 168060 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2 10.1021/jm001040g
10508016 205417 0 None -43 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 205417 0 None -43 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
132584404 142805 0 None -3 5 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
CHEMBL3897499 142805 0 None -3 5 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
135 2486 38 None -4 58 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2486 38 None -4 58 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2486 38 None -4 58 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2486 38 None -4 58 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2486 38 None -4 58 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
44324800 205210 0 None -5 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 205210 0 None -5 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
14004040 51344 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51344 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
124 2921 44 None -4 33 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2921 44 None -4 33 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2921 44 None -4 33 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2921 44 None -4 33 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2921 44 None -4 33 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
14004040 51344 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51344 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
15391752 181738 0 None -7 7 Human 7.8 pKi = 7.8 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 411 7 1 5 4.6 CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
CHEMBL4784373 181738 0 None -7 7 Human 7.8 pKi = 7.8 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 411 7 1 5 4.6 CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
44371744 50035 0 None 7 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157206 50035 0 None 7 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
11360447 84563 0 None 4 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 84563 0 None 4 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
44350012 17825 0 None 6 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL126394 17825 0 None 6 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
6604117 187254 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL2062340 187254 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL49623 187254 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
168290009 191212 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 267 1 2 5 2.0 Nc1ncc(/C=C2\CCc3c(O)cccc3C2=O)cn1 10.1016/j.ejmech.2021.113964
CHEMBL5198566 191212 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 267 1 2 5 2.0 Nc1ncc(/C=C2\CCc3c(O)cccc3C2=O)cn1 10.1016/j.ejmech.2021.113964
10660 14283 55 None -43 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14283 55 None -43 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
6918276 15420 4 None -16 8 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
CHEMBL1221512 15420 4 None -16 8 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
3198 203792 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 203792 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 203792 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
11140345 202461 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 202461 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
122442272 137807 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 137807 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 137807 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
49836306 18373 0 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276247 18373 0 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
21392988 203099 4 None -1 3 Human 4.8 pKi = 4.8 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL75201 203099 4 None -1 3 Human 4.8 pKi = 4.8 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
4209 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3102 71 None -616 34 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
1547484 925 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 925 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 925 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 925 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 925 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
3645619 2973 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
975 2973 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
CHEMBL45244 2973 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
132060720 161927 0 None -4 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4167315 161927 0 None -4 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
44415569 165370 0 None -107 6 Human 6.8 pKi = 6.8 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 505 4 1 7 4.5 COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL425069 165370 0 None -107 6 Human 6.8 pKi = 6.8 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 505 4 1 7 4.5 COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
26987 934 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
6063 934 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
671 934 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
CHEMBL1626 934 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
DB00283 934 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
9838192 110811 13 None 2 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 110811 13 None 2 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
155523897 170293 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4454147 170293 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
155556443 173902 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 406 6 0 6 3.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4554450 173902 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 406 6 0 6 3.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21 10.1021/acs.jmedchem.9b02080
9838192 110811 13 None 2 6 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 110811 13 None 2 6 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
136680384 205911 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 205911 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 205911 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
90644742 112230 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3289550 112230 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3304990 112230 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
135 2486 38 None -5 58 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
1796 2486 38 None -5 58 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
4184 2486 38 None -5 58 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
CHEMBL6437 2486 38 None -5 58 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
DB06148 2486 38 None -5 58 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
3303 2204 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 2204 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 2204 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
10319299 81161 0 None -48 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 408 4 1 4 5.7 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1 10.1021/jm060262x
CHEMBL216290 81161 0 None -48 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 408 4 1 4 5.7 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1 10.1021/jm060262x
10177445 165478 0 None -32 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
CHEMBL425622 165478 0 None -32 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
CHEMBL1441214 39563 0 None - 1 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1476898 39563 0 None - 1 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
71454275 83620 0 None -41 5 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptorDisplacement of [3H]UK 14.304 from human adrenergic alpha2A receptor
ChEMBL 293 3 1 3 3.0 CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1 10.1021/jm300975f
CHEMBL2207493 83620 0 None -41 5 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptorDisplacement of [3H]UK 14.304 from human adrenergic alpha2A receptor
ChEMBL 293 3 1 3 3.0 CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1 10.1021/jm300975f
11221758 84180 0 None 7 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
CHEMBL222138 84180 0 None 7 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
90644716 112207 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289526 112207 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304535 112207 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
16725934 146878 0 None -87 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392992 146878 0 None -87 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
44574077 178173 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468710 178173 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
136 3228 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
223 3228 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
643606 3228 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL10347 3228 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3024499 174890 67 None 20 2 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
CHEMBL45773 174890 67 None 20 2 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
11140347 202818 0 None -2 6 Human 7.7 pKi = 7.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 202818 0 None -2 6 Human 7.7 pKi = 7.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44292381 100911 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL297228 100911 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
25142456 81980 2 None -89 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human cloned adrenergic alpha 2A receptorBinding affinity to human cloned adrenergic alpha 2A receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
CHEMBL217299 81980 2 None -89 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human cloned adrenergic alpha 2A receptorBinding affinity to human cloned adrenergic alpha 2A receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
188249 39400 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL147463 39400 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL2022280 39400 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
73213195 103967 0 None -61 12 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 103967 0 None -61 12 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
164615845 184597 0 None -1 6 Human 5.8 pKi = 5.8 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
CHEMBL4857492 184597 0 None -1 6 Human 5.8 pKi = 5.8 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
5198 19220 46 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
CHEMBL12948 19220 46 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
68712 99861 57 None -1 5 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 99861 57 None -1 5 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
57395663 70822 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956193 70822 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
122065 188948 3 None -3630 8 Human 5.7 pKi = 5.7 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 188948 3 None -3630 8 Human 5.7 pKi = 5.7 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
2247 502 77 None -58 42 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 502 77 None -58 42 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 502 77 None -58 42 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 502 77 None -58 42 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 502 77 None -58 42 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
73213195 103967 0 None -61 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 103967 0 None -61 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
10379016 16300 2 None -1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL123566 16300 2 None -1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
3117 206096 100 None -2 16 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206096 100 None -2 16 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
135398737 942 89 None -26 92 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
38 942 89 None -26 92 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
722 942 89 None -26 92 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
CHEMBL42 942 89 None -26 92 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
DB00363 942 89 None -26 92 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
10362866 81873 0 None -371 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217203 81873 0 None -371 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
10474679 96716 0 None -288 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL268217 96716 0 None -288 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
44438168 93372 0 None -53 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247665 93372 0 None -53 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
44324900 205161 0 None -2 3 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90843 205161 0 None -2 3 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
11043720 91726 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 91726 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11043720 91726 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 91726 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
44289035 100035 0 None -977 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 100035 0 None -977 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
90644714 112260 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289527 112260 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305464 112260 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
155538461 171825 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4476557 171825 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644718 112250 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289525 112250 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305320 112250 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
1353 1872 85 None -190 86 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1872 85 None -190 86 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1872 85 None -190 86 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1872 85 None -190 86 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1872 85 None -190 86 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
16090601 81966 0 None -208 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
CHEMBL217254 81966 0 None -208 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
10873978 167910 0 None -4677 6 Rat 5.7 pKi = 5.7 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
CHEMBL435218 167910 0 None -4677 6 Rat 5.7 pKi = 5.7 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
135398737 942 89 None -10 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 942 89 None -10 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 942 89 None -10 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 942 89 None -10 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 942 89 None -10 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
10106205 205398 1 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
CHEMBL92221 205398 1 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
12981870 57797 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 3 2.0 C1=NCC(Cc2cc3ccccc3o2)N1 10.1021/jm001040g
CHEMBL167644 57797 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 3 2.0 C1=NCC(Cc2cc3ccccc3o2)N1 10.1021/jm001040g
10465942 13419 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1193821 13419 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL545289 13419 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
16090596 81865 0 None -275 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217177 81865 0 None -275 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
21584368 198160 3 None -4 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1021/acs.jmedchem.0c01475
CHEMBL59441 198160 3 None -4 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1021/acs.jmedchem.0c01475
90644712 112240 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289528 112240 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305159 112240 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
135398745 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
47 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
CHEMBL715 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
DB00334 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
162672516 182530 0 None -3 7 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 425 8 1 5 5.0 CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
CHEMBL4794963 182530 0 None -3 7 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 425 8 1 5 5.0 CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
127036186 136876 0 None -6 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 136876 0 None -6 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
14004039 119043 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119043 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
12699315 75930 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058631 75930 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
14004039 119043 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119043 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
44288874 100613 0 None -1949 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 100613 0 None -1949 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
11034737 202813 0 None 2 6 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 202813 0 None 2 6 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
14004032 119316 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119316 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
185076 186497 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
CHEMBL49137 186497 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
185076 186497 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
CHEMBL49137 186497 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
2142 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
4920903 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
502 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
5775 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
CHEMBL597 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
DB00692 3035 54 None 1 37 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
2142 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3035 54 None -2 37 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
124 2921 44 None -4 33 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
2032 2921 44 None -4 33 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
4636 2921 44 None -4 33 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
CHEMBL762 2921 44 None -4 33 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
DB00935 2921 44 None -4 33 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
102 4051 44 None -5 50 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4051 44 None -5 50 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4051 44 None -5 50 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4051 44 None -5 50 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4051 44 None -5 50 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
218362 203082 5 None -1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 203082 5 None -1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
73453 29388 22 None -3 17 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29388 22 None -3 17 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
135440165 78520 0 None -23 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112985 78520 0 None -23 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
136019934 143985 0 None -7 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143985 0 None -7 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
9928332 96719 4 None -1 10 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
CHEMBL268258 96719 4 None -1 10 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
9928332 96719 4 None -1 10 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
CHEMBL268258 96719 4 None -1 10 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
10176567 102314 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
CHEMBL30534 102314 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
44324765 111067 0 None -2 5 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111067 0 None -2 5 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
10176567 102314 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
CHEMBL30534 102314 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
44324765 111067 0 None -2 5 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL328114 111067 0 None -2 5 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
2142 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
4920903 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
502 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
5775 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
CHEMBL597 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
DB00692 3035 54 None -2 37 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
11959098 178946 50 None 79 2 Bovine 8.6 pKi = 8.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
CHEMBL47415 178946 50 None 79 2 Bovine 8.6 pKi = 8.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
2435 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 713 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
3038495 699 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
7625 699 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
CHEMBL25236 699 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
46934427 15437 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 481 11 1 5 4.5 COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221594 15437 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 481 11 1 5 4.5 COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
12203911 187689 20 None 54 2 Bovine 8.5 pKi = 8.5 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
CHEMBL50017 187689 20 None 54 2 Bovine 8.5 pKi = 8.5 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
9816063 102587 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
CHEMBL30739 102587 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
2216 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
229 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
7117 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
CHEMBL647 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
DB00964 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
44330584 107620 0 None -1 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319573 107620 0 None -1 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10480357 206467 0 None -9 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98541 206467 0 None -9 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9816063 102587 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
CHEMBL30739 102587 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
44314198 103920 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 103920 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 100986 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 100986 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
134551 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
11224953 78509 0 None -7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 459 6 1 5 3.3 CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112973 78509 0 None -7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 459 6 1 5 3.3 CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
135499867 78516 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 388 5 1 5 3.2 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1 10.1021/jm049619s
CHEMBL2112981 78516 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 388 5 1 5 3.2 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1 10.1021/jm049619s
1816 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
4205 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
7241 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
CHEMBL654 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
DB00370 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
49836303 18370 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276220 18370 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
2803 939 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
516 939 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
704 939 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
CHEMBL134 939 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
DB00575 939 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
49836303 18370 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276220 18370 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
10848826 188283 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50719 188283 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL508338 188369 0 None -6 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
14004032 119316 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119316 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
44415672 79749 0 None -1659 6 Human 5.7 pKi = 5.7 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 531 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL213492 79749 0 None -1659 6 Human 5.7 pKi = 5.7 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 531 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11057 175565 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 175565 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 175565 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 175565 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
44574106 177841 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466012 177841 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
135398745 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2858 108 None -93 66 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
1201549 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
11750482 146876 0 None -25 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392991 146876 0 None -25 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
12909388 60716 0 None -14 2 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL176365 60716 0 None -14 2 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
3598 187228 73 None -2 7 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
CHEMBL496 187228 73 None -2 7 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
44579187 189077 0 None -263 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189077 0 None -263 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
132060733 161563 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4161503 161563 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
11801828 204808 0 None -128 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 204808 0 None -128 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
124 2921 44 None -16 33 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
2032 2921 44 None -16 33 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
4636 2921 44 None -16 33 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
CHEMBL762 2921 44 None -16 33 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
DB00935 2921 44 None -16 33 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
123920 99678 34 None 309 2 Rat 7.7 pKi = 7.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1021/jm0205752
CHEMBL287837 99678 34 None 309 2 Rat 7.7 pKi = 7.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1021/jm0205752
4209 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 3102 71 None -3235 34 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
13141182 130358 1 None -10 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368578 130358 1 None -10 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10490084 203240 1 None 7 3 Human 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL76457 203240 1 None 7 3 Human 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
44574045 188687 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
CHEMBL512062 188687 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
50878551 90300 60 None -5 18 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL2391541 90300 60 None -5 18 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
24906197 187073 0 None 3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL495097 187073 0 None 3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
90644704 112205 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289532 112205 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304530 112205 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
4209 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3102 71 None -3235 34 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
10793665 106456 0 None -1202 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 106456 0 None -1202 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
1549008 203957 81 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
CHEMBL822 203957 81 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
44438161 146596 0 None -22 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392771 146596 0 None -22 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
2520 202301 65 None -6 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 202301 65 None -6 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 202301 65 None -6 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
12488 1619 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1619 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1619 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1619 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
11098175 202460 0 None -2 5 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202460 0 None -2 5 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
10841190 106546 0 None -309 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 106546 0 None -309 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
90644740 112220 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289549 112220 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304693 112220 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL1200633 206848 3 None -7 8 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O nan
133 2450 48 None -23 43 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2450 48 None -23 43 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2450 48 None -23 43 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2450 48 None -23 43 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2450 48 None -23 43 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
44330679 206523 0 None -10 2 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 464 7 0 8 2.9 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98889 206523 0 None -10 2 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 464 7 0 8 2.9 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324859 111109 0 None -4 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328377 111109 0 None -4 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44549156 18368 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276218 18368 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
57345626 70821 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
CHEMBL1956192 70821 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
57345626 70821 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956192 70821 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
45487956 196680 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
CHEMBL576623 196680 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
44549156 18368 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276218 18368 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
11347303 110879 0 None -1 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 110879 0 None -1 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44579185 181222 0 None -28 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181222 0 None -28 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
5288606 96723 25 None - 1 Rat 6.7 pKi = 6.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 259 0 1 1 1.9 Ic1ccc2c(c1)CNCC2 10.1021/jm0205752
CHEMBL26828 96723 25 None - 1 Rat 6.7 pKi = 6.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 259 0 1 1 1.9 Ic1ccc2c(c1)CNCC2 10.1021/jm0205752
16090602 82022 0 None -239 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL217542 82022 0 None -239 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
164618319 184000 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4848838 184000 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
10132386 96638 1 None -63 2 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C 10.1021/jm060262x
CHEMBL267464 96638 1 None -63 2 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C 10.1021/jm060262x
155566702 175323 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 472 9 0 6 4.2 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4587003 175323 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 472 9 0 6 4.2 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644722 112204 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289523 112204 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304529 112204 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
49783209 17412 0 None -3890 27 Human 5.7 pKi = 5.7 Binding
Binding affinity to human adrenergic alpha2A receptorBinding affinity to human adrenergic alpha2A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 17412 0 None -3890 27 Human 5.7 pKi = 5.7 Binding
Binding affinity to human adrenergic alpha2A receptorBinding affinity to human adrenergic alpha2A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
9906978 42451 1 None -165 12 Human 5.7 pKi = 5.7 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42451 1 None -165 12 Human 5.7 pKi = 5.7 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
9837106 103667 2 None -8 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
CHEMBL30955 103667 2 None -8 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
9837106 103667 2 None 8 4 Rat 6.7 pKi = 6.7 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
CHEMBL30955 103667 2 None 8 4 Rat 6.7 pKi = 6.7 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
1443 1989 30 None -23 11 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 1989 30 None -23 11 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 1989 30 None -23 11 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 1989 30 None -23 11 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 1989 30 None -23 11 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
2162 41258 97 None 1 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL1491 41258 97 None 1 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
12909385 60093 1 None -7 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175154 60093 1 None -7 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
135453290 133070 23 None -758 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL371300 133070 23 None -758 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
21509921 103966 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 103966 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
44288945 168338 0 None -575 7 Human 6.6 pKi = 6.6 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 168338 0 None -575 7 Human 6.6 pKi = 6.6 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
21509921 103966 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 103966 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
3080926 155043 18 None 10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/acs.jmedchem.9b02080
CHEMBL404505 155043 18 None 10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/acs.jmedchem.9b02080
44330571 163436 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL420830 163436 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330571 163436 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL420830 163436 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
9883506 70205 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 70205 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44371745 49009 0 None 11 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL156336 49009 0 None 11 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
13123527 101307 3 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300053 101307 3 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
13141184 165326 0 None -17 2 Bovine 6.6 pKi = 6.6 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL424967 165326 0 None -17 2 Bovine 6.6 pKi = 6.6 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
11198145 9707 2 None -85 5 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL113830 9707 2 None -85 5 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
16090597 140926 0 None -5 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL384318 140926 0 None -5 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
44328920 108141 0 None -199 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 108141 0 None -199 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
44325028 205233 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91297 205233 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44325079 205446 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 437 7 0 7 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92496 205446 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 437 7 0 7 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
90644732 112208 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289545 112208 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3304536 112208 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
11080 28857 74 None 1 6 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL1381098 28857 74 None 1 6 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL4549667 212235 3 None -1 2 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2A
ChEMBL None None None CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21 nan
CHEMBL4777443 212276 0 None -11 14 Human 6.6 pKi = 6.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2A
ChEMBL None None None CC(C)(C)OC(=O)N1CCCC1CN[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1 nan
24906241 192205 0 None 1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL522151 192205 0 None 1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
24906200 192543 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL523048 192543 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
135398737 942 89 None -26 92 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
38 942 89 None -26 92 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
722 942 89 None -26 92 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
CHEMBL42 942 89 None -26 92 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
DB00363 942 89 None -26 92 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
126225 94522 4 None -10 8 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 94522 4 None -10 8 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
45487089 195953 0 None 10 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570863 195953 0 None 10 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
10082076 13733 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195953 13733 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555637 13733 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
12841592 112982 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL331981 112982 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL538788 112982 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
9809007 171986 6 None -1905 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 171986 6 None -1905 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
9884781 38423 1 None 1 5 Human 6.6 pKi = 6.6 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 350 3 0 4 3.0 c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2 10.1021/acs.jmedchem.7b00151
CHEMBL146556 38423 1 None 1 5 Human 6.6 pKi = 6.6 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 350 3 0 4 3.0 c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2 10.1021/acs.jmedchem.7b00151
11624518 198649 3 None -18 7 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 352 4 0 4 3.8 Clc1ccc(-n2cc(CN3CCN(c4ccccc4)CC3)cn2)cc1 10.1016/j.ejmech.2012.08.011
CHEMBL597601 198649 3 None -18 7 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 352 4 0 4 3.8 Clc1ccc(-n2cc(CN3CCN(c4ccccc4)CC3)cn2)cc1 10.1016/j.ejmech.2012.08.011
415628 206441 89 None -2 5 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL9841 206441 89 None -2 5 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
2389 3267 114 None -44 68 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 3267 114 None -44 68 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 3267 114 None -44 68 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 3267 114 None -44 68 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 3267 114 None -44 68 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
10220232 99247 5 None -54 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
CHEMBL284795 99247 5 None -54 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
6761 67442 17 None -6 18 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67442 17 None -6 18 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
44324765 111067 0 None -2 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111067 0 None -2 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
10220232 99247 5 None 54 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
CHEMBL284795 99247 5 None 54 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
23292293 57844 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 244 2 1 2 3.0 Clc1cccc2ccc(CC3CN=CN3)cc12 10.1021/jm001040g
CHEMBL168168 57844 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 244 2 1 2 3.0 Clc1cccc2ccc(CC3CN=CN3)cc12 10.1021/jm001040g
44314200 102466 0 None -1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102466 0 None -1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
11948707 165603 0 None -616 13 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha 2A adrenergic receptor by radioligand binding assayBinding affinity to alpha 2A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
CHEMBL426317 165603 0 None -616 13 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha 2A adrenergic receptor by radioligand binding assayBinding affinity to alpha 2A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
11393666 192374 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 192374 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 192374 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
44401194 70936 0 None -33 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL195706 70936 0 None -33 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
9815610 99458 15 None -13 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
CHEMBL286246 99458 15 None -13 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
9815610 99458 15 None 13 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
CHEMBL286246 99458 15 None 13 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
5280953 96900 102 None -3 9 Human 5.6 pKi = 5.6 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
CHEMBL269538 96900 102 None -3 9 Human 5.6 pKi = 5.6 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
1752 45489 56 None -2 5 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
CHEMBL153062 45489 56 None -2 5 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
44438152 93162 0 None -134 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
CHEMBL246639 93162 0 None -134 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
2286 3122 48 None -13 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3122 48 None -13 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3122 48 None -13 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3122 48 None -13 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3122 48 None -13 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
24906242 186654 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
CHEMBL492647 186654 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
10073773 160564 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
CHEMBL4082473 160564 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
CHEMBL4117187 160564 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
10042547 75933 3 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058635 75933 3 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
155546767 173057 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 456 8 0 7 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4534152 173057 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 456 8 0 7 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL1458880 37602 0 None - 1 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
3778834 100837 70 None 144 2 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL296653 100837 70 None 144 2 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
44324725 205080 0 None -13 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90419 205080 0 None -13 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
12114850 13122 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191424 13122 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542520 13122 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
44269122 97645 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL273485 97645 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
45487144 196014 0 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
CHEMBL571314 196014 0 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
44269122 97645 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL273485 97645 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
146025727 171109 0 None -97 27 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 171109 0 None -97 27 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
90644746 112212 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289521 112212 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304553 112212 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
90644734 112209 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289546 112209 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304537 112209 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
44312198 202873 0 None 1 4 Human 4.6 pKi = 4.6 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 202873 0 None 1 4 Human 4.6 pKi = 4.6 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL4576555 212254 3 None -2 14 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 nan
9926143 113014 1 None -467 4 Rat 5.6 pKi = 5.6 Binding
Compound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptorCompound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptor
ChEMBL 294 6 2 4 3.0 O=c1ccc2ccc(CNCCNc3ccccc3)cc2o1 10.1021/jm990266k
CHEMBL332154 113014 1 None -467 4 Rat 5.6 pKi = 5.6 Binding
Compound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptorCompound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptor
ChEMBL 294 6 2 4 3.0 O=c1ccc2ccc(CNCCNc3ccccc3)cc2o1 10.1021/jm990266k
44401041 70128 0 None -63 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL194659 70128 0 None -63 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
3080926 155043 18 None 10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
CHEMBL404505 155043 18 None 10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
44579186 181384 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL478026 181384 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
9815633 99161 2 None -6 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
CHEMBL284213 99161 2 None -6 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
9815633 99161 2 None 6 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
CHEMBL284213 99161 2 None 6 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
11346584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL374584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
11346584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL374584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
11346584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL374584 136447 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
10266538 116457 2 None 1 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
CHEMBL338704 116457 2 None 1 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
4543 169972 36 None -8 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL1201156 169972 36 None -8 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL445 169972 36 None -8 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
9828476 205187 0 None -1202 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 205187 0 None -1202 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
162265 200578 19 None -12 45 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 200578 19 None -12 45 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 200578 19 None -12 45 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
73346042 91388 3 None -27542 17 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 91388 3 None -27542 17 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
4211 57502 81 None -1 4 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
CHEMBL1670 57502 81 None -1 4 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
1028 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
10176567 102314 3 None -10 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
CHEMBL30534 102314 3 None -10 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
10176567 102314 3 None 10 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
CHEMBL30534 102314 3 None 10 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
126720252 164112 0 None 12 12 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 164112 0 None 12 12 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
16655023 106942 1 None -5 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106942 1 None -5 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
44292232 100838 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 100838 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
2389 3267 114 None -87 68 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
5073 3267 114 None -87 68 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
96 3267 114 None -87 68 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
CHEMBL85 3267 114 None -87 68 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
DB00734 3267 114 None -87 68 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
57345625 70820 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956191 70820 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
44574105 178220 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL469127 178220 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
24906202 186624 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL492444 186624 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
11380133 168790 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
CHEMBL442045 168790 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
44456400 12710 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12710 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12710 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12710 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
13091268 77830 0 None -3090 14 Human 5.6 pKi = 5.6 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 77830 0 None -3090 14 Human 5.6 pKi = 5.6 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
24906159 186812 12 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 186812 12 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
11203101 71324 0 None -44 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
CHEMBL196451 71324 0 None -44 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
11811395 202985 0 None -2 4 Human 5.5 pKi = 5.5 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 202985 0 None -2 4 Human 5.5 pKi = 5.5 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
11777109 116453 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL338683 116453 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
9837106 103667 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
CHEMBL30955 103667 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
44330427 162811 0 None -4 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419336 162811 0 None -4 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9837106 103667 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
CHEMBL30955 103667 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
102 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
3659 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
8969 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
CHEMBL15245 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
DB01392 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
16655023 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
102 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
3659 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
8969 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
CHEMBL15245 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
DB01392 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
102 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
3659 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
8969 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
CHEMBL15245 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
DB01392 4051 44 None -5 50 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
12576 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
71310 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
CHEMBL353972 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
DB11481 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
10585356 120085 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
135433755 120085 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
CHEMBL354611 120085 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
78114676 169263 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 402 6 0 6 3.3 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4439953 169263 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 402 6 0 6 3.3 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
13123529 101380 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300628 101380 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
49781006 17043 0 None 2 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256565 17043 0 None 2 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
136 3228 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
223 3228 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
643606 3228 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL10347 3228 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
16655023 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
16655023 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL318235 106942 1 None -5 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
499 4002 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4002 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4002 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
2389 3267 114 None -87 68 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3267 114 None -87 68 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3267 114 None -87 68 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3267 114 None -87 68 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3267 114 None -87 68 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
2803 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
516 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
704 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
CHEMBL134 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
DB00575 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
2803 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
516 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
704 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
CHEMBL134 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
DB00575 939 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
49781887 16948 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16948 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
9990389 119913 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 2 1.8 C1=NCC(CC2Cc3ccccc3C2)N1 10.1021/jm001040g
CHEMBL353843 119913 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 2 1.8 C1=NCC(CC2Cc3ccccc3C2)N1 10.1021/jm001040g
49781007 17044 0 None -2 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256566 17044 0 None -2 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
240 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
2769 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
44279790 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
660 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
CHEMBL1729 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
CHEMBL560739 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
DB00604 929 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
44324972 162808 0 None -2 4 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 162808 0 None -2 4 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
9971924 183634 0 None 3 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL48341 183634 0 None 3 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
13123531 187648 0 None - 1 Bovine 6.5 pKi = 6.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
CHEMBL49953 187648 0 None - 1 Bovine 6.5 pKi = 6.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
9953974 77465 0 None -24 3 Human 5.5 pKi = 5.5 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL2092927 77465 0 None -24 3 Human 5.5 pKi = 5.5 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
7059292 75932 7 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
CHEMBL2058633 75932 7 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
9894818 98455 0 None -83 7 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98455 0 None -83 7 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
44401042 124296 0 None -81 9 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL364270 124296 0 None -81 9 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
11225732 93211 0 None -16 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246852 93211 0 None -16 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
10198248 186856 35 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 186856 35 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
11199581 136023 0 None 3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
CHEMBL373830 136023 0 None 3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
9944467 9146 0 None -1 4 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 9146 0 None -1 4 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
9794524 203125 2 None 10 3 Human 7.5 pKi = 7.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
CHEMBL75491 203125 2 None 10 3 Human 7.5 pKi = 7.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
10946567 16277 0 None -25 6 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 16277 0 None -25 6 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
15463615 119845 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 246 2 1 2 3.1 Clc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL353200 119845 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 246 2 1 2 3.1 Clc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
44371864 50853 0 None 8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 50853 0 None 8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
13141183 161402 1 None -15 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL415761 161402 1 None -15 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10045088 80161 0 None -407 2 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO 10.1021/jm060262x
CHEMBL214996 80161 0 None -407 2 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO 10.1021/jm060262x
16090631 81965 0 None -630 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
CHEMBL217253 81965 0 None -630 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
10632290 203028 4 None 2 3 Human 5.5 pKi = 5.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
CHEMBL74449 203028 4 None 2 3 Human 5.5 pKi = 5.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
3191 102372 93 None -8 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102372 93 None -8 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
122295 9760 6 None -9 9 Rat 6.5 pKi = 6.5 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
CHEMBL114166 9760 6 None -9 9 Rat 6.5 pKi = 6.5 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
72947315 92043 0 None -3 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
CHEMBL2431280 92043 0 None -3 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
44456400 12710 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12710 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12710 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12710 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
57400959 70829 0 None 1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 70829 0 None 1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
10337773 101101 0 None -79 10 Human 4.5 pKi = 4.5 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 101101 0 None -79 10 Human 4.5 pKi = 4.5 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
6424833 98702 94 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 178 1 1 3 1.2 O=[N+]([O-])c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL281289 98702 94 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 178 1 1 3 1.2 O=[N+]([O-])c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
10584556 206245 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 210 2 1 3 1.6 O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2 10.1016/j.bmcl.2004.12.013
CHEMBL97282 206245 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 210 2 1 3 1.6 O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2 10.1016/j.bmcl.2004.12.013
3930 2111 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
540335 2111 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
CHEMBL106525 2111 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
132075278 162082 0 None -5 5 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4169752 162082 0 None -5 5 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
44415689 138566 0 None -363 6 Human 6.5 pKi = 6.5 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 494 2 2 6 4.7 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL378669 138566 0 None -363 6 Human 6.5 pKi = 6.5 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 494 2 2 6 4.7 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11385652 78511 0 None -3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 460 6 0 6 3.7 CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112975 78511 0 None -3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 460 6 0 6 3.7 CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
118717248 114613 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
CHEMBL3343699 114613 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
4038180 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
4038180 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
11186227 84284 0 None 9 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL222798 84284 0 None 9 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
13141187 130181 0 None -9 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368475 130181 0 None -9 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
9809007 171986 6 None -1905 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 171986 6 None -1905 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
162658038 180554 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 530 10 5 13 0.4 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4760727 180554 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 530 10 5 13 0.4 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
70788951 26933 1 None -1 5 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1366 26933 1 None -1 5 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
90644726 112198 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289542 112198 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3304469 112198 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
155539605 172266 0 None -14 6 Human 5.5 pKi = 5.5 Binding
Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assayDisplacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay
ChEMBL 313 1 0 4 2.1 CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O 10.1016/j.ejmech.2018.12.048
CHEMBL4514672 172266 0 None -14 6 Human 5.5 pKi = 5.5 Binding
Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assayDisplacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay
ChEMBL 313 1 0 4 2.1 CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O 10.1016/j.ejmech.2018.12.048
8447 188352 80 None -4 13 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188352 80 None -4 13 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
11199593 136662 0 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL374954 136662 0 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44288769 100666 0 None -3090 7 Human 5.5 pKi = 5.5 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 100666 0 None -3090 7 Human 5.5 pKi = 5.5 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
10176433 20433 0 None 8 2 Human 7.5 pKi = 7.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
CHEMBL130853 20433 0 None 8 2 Human 7.5 pKi = 7.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
135398737 942 89 None -26 92 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 942 89 None -26 92 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 942 89 None -26 92 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 942 89 None -26 92 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 942 89 None -26 92 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44325027 205335 0 None -1 2 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91824 205335 0 None -1 2 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
45487958 196704 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL576819 196704 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
10376607 13234 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL1192423 13234 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL543653 13234 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
10332138 9453 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 246 1 1 3 2.2 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2 10.1016/j.bmcl.2004.12.013
CHEMBL112351 9453 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 246 1 1 3 2.2 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2 10.1016/j.bmcl.2004.12.013
5226 96603 29 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 212 1 2 3 -0.0 NS(=O)(=O)c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL26717 96603 29 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 212 1 2 3 -0.0 NS(=O)(=O)c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
75201901 165861 14 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 165861 14 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
213 3780 50 None -10 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3780 50 None -10 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3780 50 None -10 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3780 50 None -10 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3780 50 None -10 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
9798466 133742 1 None -44 6 Rat 6.5 pKi = 6.5 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL37170 133742 1 None -44 6 Rat 6.5 pKi = 6.5 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
14004037 53474 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53474 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
36324 26901 71 None - 1 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
CHEMBL1365675 26901 71 None - 1 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
14004037 53474 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53474 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
46869265 16066 0 None -16 7 Human 5.5 pKi = 5.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
CHEMBL1224527 16066 0 None -16 7 Human 5.5 pKi = 5.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
1548953 205935 24 None -1 17 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 205935 24 None -1 17 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
9895326 205289 0 None -331 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 205289 0 None -331 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
57345628 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956195 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
57345628 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956195 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
68712 99861 57 None -1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL289480 99861 57 None -1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
57345628 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL1956195 70824 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
11608298 64730 4 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 228 2 1 3 1.9 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2 10.1016/j.bmcl.2004.12.013
CHEMBL182376 64730 4 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 228 2 1 3 1.9 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2 10.1016/j.bmcl.2004.12.013
16090634 81868 0 None -4 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 296 3 1 4 3.2 Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL217180 81868 0 None -4 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 296 3 1 4 3.2 Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
3072540 81989 13 None -97 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217366 81989 13 None -97 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
9817256 202527 0 None -2 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 202527 0 None -2 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44390749 63564 0 None -199 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 63564 0 None -199 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
441383 20118 54 None -2 17 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20118 54 None -2 17 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
94459 63928 121 None 64 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL18094 63928 121 None 64 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
3086326 202816 17 None 1 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 202816 17 None 1 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
11173568 84204 0 None 8 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222371 84204 0 None 8 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
10083242 13707 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195814 13707 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555391 13707 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
3584 3706 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3706 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3706 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3706 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3706 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
9894818 98455 0 None -83 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98455 0 None -83 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
155547141 173037 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 518 9 0 7 5.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4533687 173037 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 518 9 0 7 5.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
56964794 73701 0 None -19 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 418 3 0 5 4.8 Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022272 73701 0 None -19 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 418 3 0 5 4.8 Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2 10.1021/jm2013419
12774559 189008 0 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
CHEMBL51479 189008 0 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
44574080 188349 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
CHEMBL508084 188349 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
44312036 202849 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
CHEMBL72995 202849 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
57401787 70894 0 None 1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956906 70894 0 None 1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
90644724 112200 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289522 112200 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304483 112200 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
10221005 202609 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 202609 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
10682720 203441 0 None 7 3 Human 7.4 pKi = 7.4 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
CHEMBL78190 203441 0 None 7 3 Human 7.4 pKi = 7.4 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
12981867 119838 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL353139 119838 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
49836308 18582 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278084 18582 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
11651319 181036 24 None 17 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47740 181036 24 None 17 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
21584368 198160 3 None 4 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1016/j.bmcl.2004.12.013
CHEMBL59441 198160 3 None 4 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1016/j.bmcl.2004.12.013
164585473 183969 0 None -7 5 Human 5.4 pKi = 5.4 Binding
Binding affinity to alpha2a (unknown origin)Binding affinity to alpha2a (unknown origin)
ChEMBL 503 5 1 2 7.2 O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
CHEMBL4848380 183969 0 None -7 5 Human 5.4 pKi = 5.4 Binding
Binding affinity to alpha2a (unknown origin)Binding affinity to alpha2a (unknown origin)
ChEMBL 503 5 1 2 7.2 O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
10841387 99144 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 99144 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
11079593 202406 0 None 1 4 Human 6.4 pKi = 6.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 202406 0 None 1 4 Human 6.4 pKi = 6.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10841387 99144 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 99144 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
153287574 174665 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 174665 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
24906203 186625 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL492445 186625 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
57384051 70890 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956902 70890 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
136274357 78519 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 412 4 1 5 3.8 c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
CHEMBL2112984 78519 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 412 4 1 5 3.8 c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
49864336 15426 0 None 11 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 453 9 1 5 3.7 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221545 15426 0 None 11 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 453 9 1 5 3.7 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
13507646 119096 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119096 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
13507646 119096 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119096 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
1593 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
102 4051 44 None -15 50 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
3659 4051 44 None -15 50 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
8969 4051 44 None -15 50 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL15245 4051 44 None -15 50 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
DB01392 4051 44 None -15 50 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
78114881 171205 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 288 5 0 6 0.9 CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4467833 171205 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 288 5 0 6 0.9 CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
42273326 15425 0 None 3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 403 7 1 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221544 15425 0 None 3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 403 7 1 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
136 3228 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 3228 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 3228 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 3228 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
42388639 187461 0 None -1 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 439 8 1 5 3.3 COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL497749 187461 0 None -1 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 439 8 1 5 3.3 COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
11191321 62641 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 503 6 0 7 4.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL178588 62641 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 503 6 0 7 4.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
2142 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
4920903 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
502 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
5775 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
CHEMBL597 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
DB00692 3035 54 None -2 37 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
44404326 132988 0 None 1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL370818 132988 0 None 1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
135 2486 38 None -4 58 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
1796 2486 38 None -4 58 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
4184 2486 38 None -4 58 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
CHEMBL6437 2486 38 None -4 58 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
DB06148 2486 38 None -4 58 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
9795515 203102 0 None 17 3 Human 8.3 pKi = 8.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
CHEMBL75257 203102 0 None 17 3 Human 8.3 pKi = 8.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
2585 788 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 788 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 788 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 788 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 788 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
155515982 169432 0 None -1584 17 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 169432 0 None -1584 17 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
44438147 93043 0 None -20 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246228 93043 0 None -20 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
10032383 109608 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 109608 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 109608 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
73213196 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha 2A receptor (unknown origin)Binding affinity to adrenergic alpha 2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
CHEMBL3104093 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha 2A receptor (unknown origin)Binding affinity to adrenergic alpha 2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
73213196 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
44401105 69218 0 None -45 9 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 373 2 0 3 4.7 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193435 69218 0 None -45 9 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 373 2 0 3 4.7 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1 10.1021/jm049632c
73213196 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 103968 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
11109088 202470 0 None -8 6 Human 7.4 pKi = 7.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 202470 0 None -8 6 Human 7.4 pKi = 7.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
70695474 77304 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089156 77304 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
11173544 165697 0 None 6 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL426900 165697 0 None 6 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
70695474 77304 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089156 77304 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
4209 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3102 71 None -1862 34 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
9885114 119086 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119086 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
9885114 119086 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
CHEMBL346389 119086 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
57326584 73702 0 None -4 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 396 1 0 5 4.9 Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022273 73702 0 None -4 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 396 1 0 5 4.9 Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2 10.1021/jm2013419
24906196 186653 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL492639 186653 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
11500225 100718 57 None 38 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295764 100718 57 None 38 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
44438167 148426 0 None -52 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL394218 148426 0 None -52 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
1265 927 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
6422124 927 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
CHEMBL14638 927 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
13123533 193230 1 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
CHEMBL541208 193230 1 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
62381256 112256 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289535 112256 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305460 112256 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
13869716 159721 7 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 199 1 1 3 1.5 Cn1c(C2=NCCN2)cc2ccccc21 10.1021/acs.jmedchem.9b02080
CHEMBL41103 159721 7 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 199 1 1 3 1.5 Cn1c(C2=NCCN2)cc2ccccc21 10.1021/acs.jmedchem.9b02080
71456239 78515 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 385 5 0 4 3.8 C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112979 78515 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 385 5 0 4 3.8 C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
13141185 60150 0 None -9 2 Bovine 6.4 pKi = 6.4 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175508 60150 0 None -9 2 Bovine 6.4 pKi = 6.4 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
10401405 9570 15 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 279 0 1 1 3.0 FC(F)(F)C1Cc2ccc(Br)cc2CN1 10.1016/j.bmcl.2004.12.013
CHEMBL112964 9570 15 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 279 0 1 1 3.0 FC(F)(F)C1Cc2ccc(Br)cc2CN1 10.1016/j.bmcl.2004.12.013
2719 902 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
5535 902 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
607 902 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
CHEMBL76 902 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
DB00608 902 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
45588795 112247 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289534 112247 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305316 112247 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
4098 32274 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32274 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32274 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
49836304 18369 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276219 18369 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
70693375 77303 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089155 77303 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
49836304 18369 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276219 18369 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
49836305 18374 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18374 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
70693375 77303 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089155 77303 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
9944409 7517 0 None -1 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 7517 0 None -1 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44579272 186502 0 None -14 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 186502 0 None -14 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
10397358 174405 39 None 70 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45665 174405 39 None 70 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
44579231 180975 0 None -28 3 Human 6.4 pKi = 6.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
CHEMBL476774 180975 0 None -28 3 Human 6.4 pKi = 6.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
135418497 62695 0 None -1949 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 62695 0 None -1949 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
2812 4696 96 None -32 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4696 96 None -32 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
10531532 205355 0 None -51 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 205355 0 None -51 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10199335 203029 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 203029 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
49781008 17053 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256608 17053 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
11371902 141094 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
CHEMBL385310 141094 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
11371902 141094 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL385310 141094 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
121938 141351 15 None - 1 Rat 5.4 pKi = 5.4 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 215 0 1 1 3.0 Clc1ccc2c(c1Cl)CNCCC2 10.1021/jm0205752
CHEMBL38681 141351 15 None - 1 Rat 5.4 pKi = 5.4 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 215 0 1 1 3.0 Clc1ccc2c(c1Cl)CNCCC2 10.1021/jm0205752
10436842 99779 0 None -5754 7 Human 5.3 pKi = 5.3 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 99779 0 None -5754 7 Human 5.3 pKi = 5.3 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
57326586 73703 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 402 5 1 7 2.5 OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL2022275 73703 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 402 5 1 7 2.5 OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
44438165 166220 0 None -48 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL428407 166220 0 None -48 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
16007117 79611 0 None -457 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 479 2 1 5 5.1 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL212912 79611 0 None -457 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 479 2 1 5 5.1 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
44415704 79734 0 None -158 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 474 2 2 6 4.4 Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL213424 79734 0 None -158 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 474 2 2 6 4.4 Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
155538007 171779 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4475933 171779 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
3561 18871 34 None -1 11 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 18871 34 None -1 11 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
499 4002 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4002 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4002 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
11300487 84564 0 None 5 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
CHEMBL223830 84564 0 None 5 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
10467319 202136 11 None -21 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity at alpha-2 adrenergic receptor of rat.Binding affinity at alpha-2 adrenergic receptor of rat.
ChEMBL 250 0 2 1 2.6 Brc1cccc2c3c([nH]c12)CNCC3 10.1016/j.bmcl.2003.11.078
CHEMBL6857 202136 11 None -21 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity at alpha-2 adrenergic receptor of rat.Binding affinity at alpha-2 adrenergic receptor of rat.
ChEMBL 250 0 2 1 2.6 Brc1cccc2c3c([nH]c12)CNCC3 10.1016/j.bmcl.2003.11.078
6455104 98021 5 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 172 2 1 2 1.7 C(=C/c1ccccc1)\C1=NCCN1 10.1021/acs.jmedchem.9b02080
CHEMBL275970 98021 5 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 172 2 1 2 1.7 C(=C/c1ccccc1)\C1=NCCN1 10.1021/acs.jmedchem.9b02080
15853467 206383 0 None -141 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2A adrenergic receptorBinding affinity against human Alpha-2A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 206383 0 None -141 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2A adrenergic receptorBinding affinity against human Alpha-2A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
44574134 177919 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466634 177919 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44387798 165709 0 None -4 2 Human 7.3 pKi = 7.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 458 7 0 5 3.9 CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL426959 165709 0 None -4 2 Human 7.3 pKi = 7.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 458 7 0 5 3.9 CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
11108001 10756 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10756 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10756 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44352207 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
44352207 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44352207 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18653 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
162674829 182682 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 513 11 5 11 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4796664 182682 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 513 11 5 11 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
164614469 184188 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 341 1 0 3 3.9 C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4851349 184188 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 341 1 0 3 3.9 C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
3034396 101155 33 None -77 17 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 101155 33 None -77 17 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC 10.1021/acs.jmedchem.9b01465
44269013 30113 1 None 1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL13917 30113 1 None 1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
45487962 195799 0 None 10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL569933 195799 0 None 10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
11776640 13420 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1193824 13420 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL545293 13420 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
163198500 185806 2 None -3 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 371 1 0 3 3.2 O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F 10.1016/j.bmcl.2021.128008
CHEMBL4875858 185806 2 None -3 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 371 1 0 3 3.2 O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F 10.1016/j.bmcl.2021.128008
15407445 198584 2 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 192 1 1 3 1.6 CC1Cc2ccc([N+](=O)[O-])cc2CN1 10.1016/j.bmcl.2004.12.013
CHEMBL59719 198584 2 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 192 1 1 3 1.6 CC1Cc2ccc([N+](=O)[O-])cc2CN1 10.1016/j.bmcl.2004.12.013
132060743 161674 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4163428 161674 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
57395732 70832 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956203 70832 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
70696790 75931 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058632 75931 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
90644748 112225 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289520 112225 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304855 112225 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
155517797 169635 0 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 498 8 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4445396 169635 0 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 498 8 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21 10.1021/acs.jmedchem.9b02080
102 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3659 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
8969 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL15245 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
DB01392 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
102 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
3659 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
8969 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
CHEMBL15245 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
DB01392 4051 44 None -47 50 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
191 399 92 None -41 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 399 92 None -41 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 399 92 None -41 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 399 92 None -41 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 399 92 None -41 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
13298530 98602 18 None 97 2 Bovine 8.3 pKi = 8.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
CHEMBL280514 98602 18 None 97 2 Bovine 8.3 pKi = 8.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
44215744 205699 0 None -1 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL94129 205699 0 None -1 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
521 1372 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
5311068 1372 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
835 1372 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
CHEMBL778 1372 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
DB00633 1372 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
42267840 15413 2 None 4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 425 7 1 5 2.9 COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221499 15413 2 None 4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 425 7 1 5 2.9 COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
44330857 4313 0 None -5 2 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101361 4313 0 None -5 2 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
294234 102407 3 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102407 3 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
31101 719 39 None -12 36 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 719 39 None -12 36 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 719 39 None -12 36 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 719 39 None -12 36 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 719 39 None -12 36 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
13123525 188599 0 None - 1 Bovine 8.3 pKi = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
CHEMBL51131 188599 0 None - 1 Bovine 8.3 pKi = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
44330598 205894 0 None -8 2 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL95218 205894 0 None -8 2 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10220053 205183 0 None 3 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
CHEMBL90997 205183 0 None 3 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
10220053 205183 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
CHEMBL90997 205183 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
1343 1850 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1850 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1850 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1850 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1850 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
100 3733 52 None -33 56 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3733 52 None -33 56 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3733 52 None -33 56 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3733 52 None -33 56 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3733 52 None -33 56 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
73291731 92045 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL2431282 92045 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
117590588 96064 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
14969 96064 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
CHEMBL262777 96064 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
24906199 187072 12 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187072 12 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
45487955 196623 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL576078 196623 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
2771431 187688 47 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
CHEMBL50016 187688 47 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
9923679 81336 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
CHEMBL216399 81336 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
162651072 179590 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 527 12 5 11 1.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4749263 179590 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 527 12 5 11 1.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
137641762 157542 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4086593 157542 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
137643541 157873 0 None -4 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 448 3 4 10 0.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4090355 157873 0 None -4 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 448 3 4 10 0.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.7b00141
3158 55959 21 None -3467 20 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 55959 21 None -3467 20 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
10651080 105449 0 None -57 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 105449 0 None -57 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
57398332 70888 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc(C2COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956900 70888 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc(C2COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
10916464 202443 0 None -10 5 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 202443 0 None -10 5 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
44579184 190349 4 None -10 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190349 4 None -10 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
132060776 161840 0 None -1 16 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 161840 0 None -1 16 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
11820657 13318 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL1193017 13318 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL544354 13318 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
10036255 21144 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131417 21144 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
10036256 23562 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL133579 23562 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
11277479 84312 0 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
CHEMBL222973 84312 0 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
10214826 4397 15 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 289 2 2 4 2.9 Brc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
CHEMBL1019 4397 15 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 289 2 2 4 2.9 Brc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
130442572 171332 0 None -109 24 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 171332 0 None -109 24 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
90644706 112233 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289531 112233 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304994 112233 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
4735 193435 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 193435 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 193435 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
3584 3706 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3706 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3706 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3706 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3706 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10101373 12967 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1190317 12967 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL540594 12967 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
24882007 12352 1 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
CHEMBL1186220 12352 1 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
49836301 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276140 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
49836301 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276140 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
49836301 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276140 18365 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
16785637 180985 77 None 11 2 Bovine 5.3 pKi = 5.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47688 180985 77 None 11 2 Bovine 5.3 pKi = 5.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
162664704 181619 0 None - 1 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4783068 181619 0 None - 1 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
73347825 92094 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 311 5 1 3 2.9 COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC 10.1016/j.bmc.2013.07.045
CHEMBL2432046 92094 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 311 5 1 3 2.9 COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC 10.1016/j.bmc.2013.07.045
145973771 164156 0 None -6 7 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 797 16 2 7 10.8 CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4217398 164156 0 None -6 7 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 797 16 2 7 10.8 CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
448537 159691 86 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 159691 86 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
155521287 170001 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4450506 170001 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
487 3564 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 3564 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 3564 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 3564 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
10059780 12835 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1189347 12835 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL538537 12835 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
289 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
2801 161313 56 None -14 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL1200710 161313 56 None -14 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL415 161313 56 None -14 29 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
162643475 181151 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha 2A adrenoceptor (unknown origin)Binding affinity to alpha 2A adrenoceptor (unknown origin)
ChEMBL 283 1 0 2 4.3 C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1 10.1021/acs.jmedchem.0c01192
CHEMBL4777306 181151 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha 2A adrenoceptor (unknown origin)Binding affinity to alpha 2A adrenoceptor (unknown origin)
ChEMBL 283 1 0 2 4.3 C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1 10.1021/acs.jmedchem.0c01192
15730 70759 73 None -2 10 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 70759 73 None -2 10 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
155521287 170001 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4450506 170001 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
57394788 70891 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956903 70891 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
10092819 16579 0 None -51 12 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
CHEMBL124444 16579 0 None -51 12 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
44424855 85015 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85015 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
518 3542 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 3542 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 3542 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
49781005 17017 0 None 3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17017 0 None 3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
6075 149563 36 None -11 16 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 149563 36 None -11 16 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
155548049 173115 0 None -3 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2cccc(O)c2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
CHEMBL4535634 173115 0 None -3 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2cccc(O)c2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
135559170 101577 0 None -851 7 Human 6.3 pKi = 6.3 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 101577 0 None -851 7 Human 6.3 pKi = 6.3 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
3584 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
9813756 8913 0 None -1 3 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 8913 0 None -1 3 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
13123534 188853 1 None - 1 Bovine 7.3 pKi = 7.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
CHEMBL51358 188853 1 None - 1 Bovine 7.3 pKi = 7.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
2142 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 3035 54 None -2 37 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
3584 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 3706 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
12613159 186733 7 None -16 4 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL493054 186733 7 None -16 4 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
11465618 101913 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 101913 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 101913 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
9816461 10604 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10604 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10604 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
24906198 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL495095 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
57402717 70828 2 None 14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956199 70828 2 None 14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24906198 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL495095 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
45487145 195972 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570973 195972 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
24906198 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
CHEMBL495095 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
24906198 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
CHEMBL495095 187071 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
44329027 4089 0 None -29 6 Human 6.2 pKi = 6.2 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 4089 0 None -29 6 Human 6.2 pKi = 6.2 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
11097789 102511 0 None -11 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102511 0 None -11 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
2765 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
515 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
CHEMBL13852 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
DB09202 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
2765 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
515 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
CHEMBL13852 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
DB09202 928 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
16090621 141031 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
CHEMBL384925 141031 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
1960 2805 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
439260 2805 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
505 2805 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL1437 2805 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
DB00368 2805 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
9906978 42451 1 None -165 12 Human 5.2 pKi = 5.2 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42451 1 None -165 12 Human 5.2 pKi = 5.2 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
6726 1249 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
7151 1249 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
749 1249 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL648 1249 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB01176 1249 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
150 2463 18 None -45 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2463 18 None -45 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2463 18 None -45 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2463 18 None -45 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2463 18 None -45 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
9859437 167448 0 None 38 3 Human 8.2 pKi = 8.2 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 167448 0 None 38 3 Human 8.2 pKi = 8.2 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
49864360 15436 0 None 15 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 445 10 1 4 5.0 COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221593 15436 0 None 15 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 445 10 1 4 5.0 COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
11653915 123481 0 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 123481 0 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
1209 1620 69 None -1 32 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
203 1620 69 None -1 32 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
3386 1620 69 None -1 32 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
CHEMBL41 1620 69 None -1 32 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
DB00472 1620 69 None -1 32 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
131829 203010 11 None 7 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 203010 11 None 7 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
135477797 78507 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112971 78507 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
2435 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 713 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
10382537 202456 11 None 6 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 202456 11 None 6 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
98358 118968 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 118968 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
98358 118968 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 118968 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
11361608 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL222928 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
11361608 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222928 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
11361608 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL222928 84307 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
13141186 130156 0 None -7 2 Bovine 6.2 pKi = 6.2 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368357 130156 0 None -7 2 Bovine 6.2 pKi = 6.2 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
9851486 204962 0 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 204962 0 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
155525779 170465 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.3 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4456882 170465 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.3 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11771731 107747 2 None -16 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL319706 107747 2 None -16 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
134 2468 19 None -74 68 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2468 19 None -74 68 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2468 19 None -74 68 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2468 19 None -74 68 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2468 19 None -74 68 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
489 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10082625 13666 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1195526 13666 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL554785 13666 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2750 202354 69 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 202354 69 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
2351 3222 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3222 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3222 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3222 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3222 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
129211 3680 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 3680 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 3680 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 3680 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 3680 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2274 3112 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3112 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3112 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3112 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3112 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
10934575 202771 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 202771 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
10823140 119847 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
136078488 119847 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
CHEMBL353212 119847 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
75306277 108754 0 None -31 23 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 108754 0 None -31 23 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
155550341 174521 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 458 8 0 6 4.2 CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4568994 174521 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 458 8 0 6 4.2 CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
1042 1544 20 None -97 17 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1544 20 None -97 17 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1544 20 None -97 17 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1544 20 None -97 17 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1544 20 None -97 17 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
16090635 82089 0 None -5 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
CHEMBL217768 82089 0 None -5 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
10508332 105498 0 None -426 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 105498 0 None -426 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
10626982 110994 0 None -11 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 110994 0 None -11 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
1534 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
155536080 171538 0 None -43 10 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4472703 171538 0 None -43 10 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
57394789 70892 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956904 70892 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
1534 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 102553 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
162677211 182968 0 None - 1 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 516 9 5 13 -0.0 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4800292 182968 0 None - 1 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 516 9 5 13 -0.0 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
487 3564 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
60602 3564 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
CHEMBL405355 3564 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
DB09239 3564 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
10793963 99198 0 None -69 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 99198 0 None -69 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
71652196 87012 0 None -190 7 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 368 4 1 5 3.6 Oc1ccc(N2CCN(Cc3cnn(-c4ccc(Cl)cc4)c3)CC2)cc1 10.1016/j.ejmech.2012.08.011
CHEMBL2333732 87012 0 None -190 7 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 368 4 1 5 3.6 Oc1ccc(N2CCN(Cc3cnn(-c4ccc(Cl)cc4)c3)CC2)cc1 10.1016/j.ejmech.2012.08.011
3652 45968 62 None -1 9 Human 5.2 pKi = 5.2 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
CHEMBL1535 45968 62 None -1 9 Human 5.2 pKi = 5.2 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
118717249 114614 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
CHEMBL3343700 114614 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
11741010 82824 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL218730 82824 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
164609539 183807 0 None 2 3 Human 6.2 pKi = 6.2 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4845850 183807 0 None 2 3 Human 6.2 pKi = 6.2 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
123920 99678 34 None -309 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL287837 99678 34 None -309 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1016/j.bmcl.2004.12.013
71459553 83268 5 None -3 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 406 7 0 4 5.3 COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1 10.1016/j.bmc.2012.09.044
CHEMBL2205360 83268 5 None -3 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 406 7 0 4 5.3 COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1 10.1016/j.bmc.2012.09.044
1960 2805 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
439260 2805 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
505 2805 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
CHEMBL1437 2805 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
DB00368 2805 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
44325044 205641 0 None -5 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93801 205641 0 None -5 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44401164 69458 0 None -346 9 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193639 69458 0 None -346 9 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
44579271 186501 0 None -32 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 186501 0 None -32 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
14004035 119001 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119001 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
14004035 119001 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119001 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
24906160 168878 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL442815 168878 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
441082 1136 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
8981 1136 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
CHEMBL191703 1136 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
122442272 137807 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 137807 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 137807 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
240 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 929 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
196129 67441 12 None -85 15 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67441 12 None -85 15 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
26757 206229 29 None -1 2 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 206229 29 None -1 2 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
10818003 105927 0 None -12 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 105927 0 None -12 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10603951 204780 0 None -33 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 204780 0 None -33 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
90644753 112258 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289537 112258 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3305462 112258 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
3073596 43981 24 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 184 1 1 2 2.8 c1ccc2oc(-c3ncc[nH]3)cc2c1 10.1021/acs.jmedchem.9b02080
CHEMBL151697 43981 24 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 184 1 1 2 2.8 c1ccc2oc(-c3ncc[nH]3)cc2c1 10.1021/acs.jmedchem.9b02080
9816063 102587 0 None -4 6 Human 7.2 pKi = 7.2 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
CHEMBL30739 102587 0 None -4 6 Human 7.2 pKi = 7.2 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
9816063 102587 0 None 4 6 Rat 7.2 pKi = 7.2 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
CHEMBL30739 102587 0 None 4 6 Rat 7.2 pKi = 7.2 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
16090625 82004 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217452 82004 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
130442480 174688 0 None -83 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 174688 0 None -83 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
155556618 173895 0 None -6456 5 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 417 6 3 7 2.7 O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O 10.1021/acs.jmedchem.8b01662
CHEMBL4554295 173895 0 None -6456 5 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 417 6 3 7 2.7 O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O 10.1021/acs.jmedchem.8b01662
4011 81982 43 None -35 24 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 81982 43 None -35 24 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
28417 39784 48 None -1 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 39784 48 None -1 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
26987 934 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 934 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 934 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 934 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 934 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
16215415 186739 1 None 3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
CHEMBL493091 186739 1 None 3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
44330621 4321 0 None -6 2 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 483 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101411 4321 0 None -6 2 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 483 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
90644738 112223 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3289548 112223 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3304843 112223 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
155526672 170633 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 528 7 0 6 6.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4459403 170633 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 528 7 0 6 6.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
155535203 171465 0 None -18 6 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 403 5 3 7 2.8 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
CHEMBL4471712 171465 0 None -18 6 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 403 5 3 7 2.8 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
10198108 206454 2 None 7 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL98471 206454 2 None 7 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
12575 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
54459 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
CHEMBL10316 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
12575 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
54459 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
CHEMBL10316 1949 28 None -5 17 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
12774559 189008 0 None - 1 Bovine 8.2 pKi = 8.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
CHEMBL51479 189008 0 None - 1 Bovine 8.2 pKi = 8.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
185076 186497 4 None 2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 186497 4 None 2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
213041 16937 24 None -1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
CHEMBL1255582 16937 24 None -1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
102 4051 44 None -5 50 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 4051 44 None -5 50 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 4051 44 None -5 50 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 4051 44 None -5 50 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 4051 44 None -5 50 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
155513073 169137 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 440 8 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4438158 169137 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 440 8 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11412944 101026 65 None 223 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL298004 101026 65 None 223 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
135545454 78518 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 448 7 1 7 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112983 78518 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 448 7 1 7 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
2803 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
13123533 193230 1 None - 1 Bovine 7.2 pKi = 7.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
CHEMBL541208 193230 1 None - 1 Bovine 7.2 pKi = 7.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
155544935 172835 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 460 7 0 6 4.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4528557 172835 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 460 7 0 6 4.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
162654541 180021 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 499 10 5 11 0.8 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4754656 180021 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 499 10 5 11 0.8 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
10045713 165541 0 None -309 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
CHEMBL425983 165541 0 None -309 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
122186880 122452 0 None -7 5 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha2A adrenoceptor (unknown origin)Binding affinity to alpha2A adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
CHEMBL3608450 122452 0 None -7 5 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha2A adrenoceptor (unknown origin)Binding affinity to alpha2A adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
44401106 123795 0 None -112 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL363581 123795 0 None -112 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
57345627 70823 0 None 8 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956194 70823 0 None 8 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
44269089 96544 0 None 6 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL266613 96544 0 None 6 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
16757182 152705 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL397753 152705 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757182 152705 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL397753 152705 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
11183468 109371 2 None -1 6 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 109371 2 None -1 6 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
4567175 82050 5 None 2 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217665 82050 5 None 2 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
24906201 186760 0 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL493272 186760 0 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
1016 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3678 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
3157 1437 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
7170 1437 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
954 1437 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
CHEMBL707 1437 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
DB00590 1437 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
56964693 73699 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 314 0 1 5 2.8 Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022269 73699 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 314 0 1 5 2.8 Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2 10.1021/jm2013419
12841596 116944 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL2448004 116944 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL339883 116944 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
12909383 130168 1 None -5 2 Bovine 6.1 pKi = 6.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368413 130168 1 None -5 2 Bovine 6.1 pKi = 6.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
44292470 101151 4 None 57 2 Bovine 7.1 pKi = 7.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
CHEMBL299007 101151 4 None 57 2 Bovine 7.1 pKi = 7.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
136044137 78512 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 472 6 1 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112976 78512 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 472 6 1 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2 10.1021/jm049619s
25130235 186994 1 None -2 11 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 294 2 1 6 1.3 CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1 10.1021/jm8005959
CHEMBL494678 186994 1 None -2 11 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 294 2 1 6 1.3 CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1 10.1021/jm8005959
15675860 202714 0 None 4 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL72147 202714 0 None 4 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
23622576 172193 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172193 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
3823 49936 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 49936 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 49936 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1577 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
164512405 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
2537 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5355 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5501 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
643497 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
688272 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
958 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
960 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL196677 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL26 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL267044 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB00391 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB16021 3634 104 None -2 26 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
10674896 204908 0 None -416 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 204908 0 None -416 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
657255 197396 29 None -10 15 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
CHEMBL588119 197396 29 None -10 15 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
155567867 175449 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 502 8 0 6 5.7 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4590209 175449 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 502 8 0 6 5.7 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
10454026 17710 0 None -234 9 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
CHEMBL125916 17710 0 None -234 9 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
10895039 18319 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL127400 18319 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL129022 18319 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
10655607 203037 5 None 5 3 Human 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
CHEMBL74544 203037 5 None 5 3 Human 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
10326069 39044 1 None -42 9 Human 6.1 pKi = 6.1 Binding
Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39044 1 None -42 9 Human 6.1 pKi = 6.1 Binding
Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
53324553 56545 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmc.2013.07.045
CHEMBL1643900 56545 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmc.2013.07.045
53324553 56545 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmcl.2010.11.075
CHEMBL1643900 56545 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmcl.2010.11.075
1210 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
1213 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
2725 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
33036 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
4411 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
616 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
6976 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
716121 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
90475904 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 903 45 None -263 21 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
72947314 92044 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
CHEMBL2431281 92044 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
490 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
12909389 60035 0 None -64 2 Bovine 4.1 pKi = 4.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL174649 60035 0 None -64 2 Bovine 4.1 pKi = 4.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
16090598 82029 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217568 82029 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
5467 204202 40 None -6 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
CHEMBL84158 204202 40 None -6 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
44288847 164746 0 None -5495 5 Human 5.1 pKi = 5.1 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 164746 0 None -5495 5 Human 5.1 pKi = 5.1 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
5897 104719 71 None -7 3 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
CHEMBL311469 104719 71 None -7 3 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
44401164 69458 0 None -346 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193639 69458 0 None -346 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
90644744 112231 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289551 112231 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304991 112231 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
16090623 82028 0 None -102 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217567 82028 0 None -102 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
44415690 79712 0 None -363 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 473 2 1 5 5.1 Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL213336 79712 0 None -363 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 473 2 1 5 5.1 Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
10923927 202468 0 None -1 4 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
CHEMBL70740 202468 0 None -1 4 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
6604789 100565 3 None -31 10 Human 5.1 pKi = 5.1 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL294649 100565 3 None -31 10 Human 5.1 pKi = 5.1 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
57399991 70889 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956901 70889 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
12575 1949 28 None -5 17 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
54459 1949 28 None -5 17 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
CHEMBL10316 1949 28 None -5 17 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
134987 186089 43 None 309 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48833 186089 43 None 309 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
441975 16259 49 None -1 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL123325 16259 49 None -1 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
49864359 15435 0 None 3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 467 10 1 5 4.1 COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221592 15435 0 None 3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 467 10 1 5 4.1 COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
124 2921 44 None -4 33 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2921 44 None -4 33 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2921 44 None -4 33 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2921 44 None -4 33 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2921 44 None -4 33 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2803 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
516 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
704 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
CHEMBL134 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
DB00575 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
10775000 106897 2 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 106897 2 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44324765 111067 0 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328114 111067 0 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9846548 205584 0 None -1 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93489 205584 0 None -1 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
1212 1624 45 None -165 66 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1624 45 None -165 66 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1624 45 None -165 66 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1624 45 None -165 66 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1624 45 None -165 66 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
9960497 99997 0 None -2454 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 99997 0 None -2454 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
16090628 141243 0 None -933 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL386169 141243 0 None -933 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
44574075 171998 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448802 171998 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
4601 205010 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 205010 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 205010 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
10466448 112371 2 None 34 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
CHEMBL330994 112371 2 None 34 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
44579229 189014 0 None -39 3 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189014 0 None -39 3 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
11000184 12926 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 12926 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 12926 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
10859076 13555 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13555 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13555 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
127036932 136811 0 None -2 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 136811 0 None -2 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
16757089 91845 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL242693 91845 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757089 91845 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL242693 91845 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
11448533 84253 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
CHEMBL222591 84253 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
11473729 84254 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
CHEMBL222593 84254 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
136680386 205959 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 205959 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 205959 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
491 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
1530 2142 44 None -70 21 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2142 44 None -70 21 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2142 44 None -70 21 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2142 44 None -70 21 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2142 44 None -70 21 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3038495 699 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
7625 699 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
CHEMBL25236 699 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
57345629 70826 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956197 70826 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
127036953 136977 0 None -8 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 136977 0 None -8 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
44269140 33319 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL14208 33319 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57345629 70826 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956197 70826 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
9817231 157679 17 None 1 7 Human 5.1 pKi = 5.1 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
CHEMBL4088272 157679 17 None 1 7 Human 5.1 pKi = 5.1 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
90644755 112218 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289538 112218 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304668 112218 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
10044968 96085 0 None -54 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL262901 96085 0 None -54 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
56852956 111538 1 None -218 10 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 111538 1 None -218 10 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
9904606 9281 0 None 2 4 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 9281 0 None 2 4 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
16090594 81699 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL216674 81699 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
56852956 111538 1 None -218 10 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 111538 1 None -218 10 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
2803 939 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
516 939 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
704 939 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
CHEMBL134 939 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
DB00575 939 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
2803 939 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
516 939 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
704 939 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL134 939 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
DB00575 939 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
237 203147 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 203147 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 203147 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 203147 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
11293787 147669 0 None -77 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL393597 147669 0 None -77 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
155552185 173479 0 None -1548 16 Human 6.1 pKi = 6.1 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4544086 173479 0 None -1548 16 Human 6.1 pKi = 6.1 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
44582676 189177 0 None -269 18 Human 6.1 pKi = 6.1 Binding
Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL516088 189177 0 None -269 18 Human 6.1 pKi = 6.1 Binding
Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
10398419 116128 0 None 13 2 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336970 116128 0 None 13 2 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
136019934 143985 0 None -7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143985 0 None -7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
44350063 117432 0 None - 1 Bovine 6.1 pKi = 6.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 349 4 3 7 -0.0 C1=CN2CCN=C2C(N2CCNCC2)=N1.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL340358 117432 0 None - 1 Bovine 6.1 pKi = 6.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 349 4 3 7 -0.0 C1=CN2CCN=C2C(N2CCNCC2)=N1.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
11058166 202989 0 None -2 5 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 202989 0 None -2 5 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
9931977 62696 0 None -616 4 Human 6.1 pKi = 6.1 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 62696 0 None -616 4 Human 6.1 pKi = 6.1 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
132060763 162299 0 None -3 8 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4173095 162299 0 None -3 8 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
44415593 79822 0 None -891 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 495 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL213834 79822 0 None -891 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 495 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11732785 163157 0 None -102 6 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
CHEMBL420510 163157 0 None -102 6 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
10473701 82811 0 None -165 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
CHEMBL218679 82811 0 None -165 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
44424855 85015 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85015 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44330609 162888 0 None 2 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419894 162888 0 None 2 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
135405894 78505 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 470 8 1 8 2.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112969 78505 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 470 8 1 8 2.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2 10.1021/jm049619s
10028898 111151 0 None -11 2 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328631 111151 0 None -11 2 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
123981 16267 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 16267 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 16267 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
9816048 186685 0 None 12 3 Human 8.0 pKi = 8.0 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
CHEMBL49284 186685 0 None 12 3 Human 8.0 pKi = 8.0 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
463 1373 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 1373 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 1373 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 1373 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 1373 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
16090627 81141 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
CHEMBL216197 81141 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
2683 102402 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102402 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102402 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
10333157 150694 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 150694 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11140033 20468 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20468 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
10333157 150694 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 150694 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
16090595 140857 0 None -109 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL383978 140857 0 None -109 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
10651654 110982 0 None -489 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 110982 0 None -489 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10084076 97454 0 None -5 9 Human 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
CHEMBL27251 97454 0 None -5 9 Human 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
44324737 205498 0 None -2 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 205498 0 None -2 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44568614 187030 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL494885 187030 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
2337 3193 72 None -50 63 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3193 72 None -50 63 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3193 72 None -50 63 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3193 72 None -50 63 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3193 72 None -50 63 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5280805 84967 76 None -28 3 Human 5.0 pKi = 5.0 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 10.1021/np1000329
CHEMBL226335 84967 76 None -28 3 Human 5.0 pKi = 5.0 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 10.1021/np1000329
25110718 192696 0 None -72 3 Human 7.0 pKi = 7.0 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL524153 192696 0 None -72 3 Human 7.0 pKi = 7.0 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
10527469 155712 1 None -204 16 Human 7.0 pKi = 7.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 155712 1 None -204 16 Human 7.0 pKi = 7.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
164609730 184506 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 398 2 1 5 3.5 CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4856060 184506 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 398 2 1 5 3.5 CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
71463022 83270 4 None 1 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 436 8 0 5 5.3 COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC 10.1016/j.bmc.2012.09.044
CHEMBL2205362 83270 4 None 1 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 436 8 0 5 5.3 COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC 10.1016/j.bmc.2012.09.044
24841480 183307 0 None -47 20 Human 7.0 pKi = 7.0 Binding
Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL481153 183307 0 None -47 20 Human 7.0 pKi = 7.0 Binding
Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
10489502 4436 2 None 6 3 Human 7.0 pKi = 7.0 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL1022 4436 2 None 6 3 Human 7.0 pKi = 7.0 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
28918670 92041 2 None 4 4 Human 7.0 pKi = 7.0 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL2431279 92041 2 None 4 4 Human 7.0 pKi = 7.0 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
10508132 106521 0 None -16 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 106521 0 None -16 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
10507651 204771 0 None -107 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 204771 0 None -107 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
9950711 108706 0 None -5 4 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL321644 108706 0 None -5 4 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
14004033 48952 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 48952 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
78114671 173582 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 350 6 0 6 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4546903 173582 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 350 6 0 6 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
44328654 106688 0 None -251 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 106688 0 None -251 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
21830793 91389 5 None -630 46 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 91389 5 None -630 46 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
139406787 176561 0 None 2 4 Human 6.0 pKi = 6.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
CHEMBL4633982 176561 0 None 2 4 Human 6.0 pKi = 6.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
10251036 81459 0 None -162 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL216464 81459 0 None -162 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
14004033 48952 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 48952 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
16090632 141172 0 None -46 3 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
CHEMBL385722 141172 0 None -46 3 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
2777786 174395 77 None 29 2 Bovine 7.0 pKi = 7.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45663 174395 77 None 29 2 Bovine 7.0 pKi = 7.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
57399145 70825 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956196 70825 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
49836307 18583 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278085 18583 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
9879119 9340 0 None -4 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 9340 0 None -4 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
11747739 13109 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13109 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13109 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44324860 205755 0 None -1 2 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL94435 205755 0 None -1 2 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
16090633 80036 0 None -25 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL214661 80036 0 None -25 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
4209 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3102 71 None -3235 34 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
44329026 206673 0 None -19 6 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 206673 0 None -19 6 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
2105 2993 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 2993 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 2993 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 2993 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 2993 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
44574078 178174 0 None - 1 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468711 178174 0 None - 1 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
168274641 189831 0 None - 1 Rat 5.0 pKi = 5 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2ccc(O)cc2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
CHEMBL5178192 189831 0 None - 1 Rat 5.0 pKi = 5 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2ccc(O)cc2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
2477 732 54 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 732 54 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 732 54 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 732 54 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 732 54 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
3689 102285 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
CHEMBL1372983 102285 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
CHEMBL305187 102285 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
2803 939 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3294 1967 106 None - 45 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1967 106 None - 45 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1967 106 None - 45 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1967 106 None - 45 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1967 106 None - 45 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1795 1555 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
4186 1555 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
CHEMBL517986 1555 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
1192 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
1192 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
1794 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
1794 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
CHEMBL501701 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
CHEMBL501701 147 41 None -51286 17 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
108094 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
108094 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
526 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
526 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
528 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
528 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
CHEMBL10332 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
CHEMBL10332 3356 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
136 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
136 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
223 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
223 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
643606 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
643606 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
CHEMBL10347 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL10347 3228 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
1588 2284 24 3H-RX821002 2 44 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2284 24 3H-RX821002 2 44 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2284 24 3H-RX821002 2 44 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2284 24 3H-RX821002 2 44 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2284 24 3H-RX821002 2 44 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL1196898 214249 0 3H-RAUWOLSCINE 1 3 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 248 3 1 5 1.2 CCOC1(COC2=CC=CC=C2O1)C3=NCCN3 None
2601 3709 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3709 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3709 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3709 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3709 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
138107169 214163 0 3H-RAUWOLSCINE -6 23 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-RAUWOLSCINE -6 23 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
12576 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
71310 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
CHEMBL353972 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
DB11481 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
108094 3356 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3356 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3356 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3356 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
None 214248 0 3H-RAUWOLSCINE -2 3 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 953 28 10 12 0.9 CCOC1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(C=S)C(=O)NC(CCCCN)C(=O)N)NC(=O)CC3(CCCCC3)S None
138107169 214163 0 3H-RX821002 1 23 Pig 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-RX821002 1 23 Pig 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214247 0 3H-RAUWOLSCINE -13 3 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 339 0 0 3 3.3 CN1CCC2(CCN3CCC4=C(C3C2)OC5=CC=CC=C45)N(C1=O)C None
138107169 214163 0 3H-RAUWOLSCINE -6 23 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-RAUWOLSCINE -6 23 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
102 4051 44 3H-RAUWOLSCINE -5 50 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-RAUWOLSCINE -5 50 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-RAUWOLSCINE -5 50 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-RAUWOLSCINE -5 50 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-RAUWOLSCINE -5 50 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
108094 3356 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
108094 3356 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3356 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3356 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3356 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3356 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3356 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3356 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
102 4051 44 3H-RAUWOLSCINE -5 50 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-RAUWOLSCINE -5 50 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-RAUWOLSCINE -5 50 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-RAUWOLSCINE -5 50 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-RAUWOLSCINE -5 50 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
164512323 214250 0 3H-RAUWOLSCINE -5 5 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RAUWOLSCINE -5 5 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
124 2921 44 3H-RAUWOLSCINE -4 33 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RAUWOLSCINE -4 33 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RAUWOLSCINE -4 33 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RAUWOLSCINE -4 33 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RAUWOLSCINE -4 33 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 214169 0 3H-RAUWOLSCINE -14 20 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
108094 3356 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3356 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3356 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3356 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
None 214172 0 3H-RAUWOLSCINE -1 5 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 295 5 2 3 3.0 C1CC2=CC=CC=C2C(=O)C1CNCCC3=CC=C(C=C3)O None
None 214169 0 3H-RX821002 -6 20 Pig 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
108094 3356 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3356 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3356 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3356 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
138107169 214163 0 35S-GTPGammaS -6 23 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 35S-GTPGammaS -6 23 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214169 0 3H-RAUWOLSCINE -14 20 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
41 1621 0 3H-PRAZOSIN -1 17 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1621 0 3H-PRAZOSIN -1 17 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1621 0 3H-PRAZOSIN -1 17 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
None 214169 0 3H-RAUWOLSCINE -14 20 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
124 2921 44 3H-RAUWOLSCINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RAUWOLSCINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RAUWOLSCINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RAUWOLSCINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RAUWOLSCINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2921 44 3H-CLONIDINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-CLONIDINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-CLONIDINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-CLONIDINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-CLONIDINE -4 33 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2921 44 3H-RAUWOLSCINE -4 33 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RAUWOLSCINE -4 33 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RAUWOLSCINE -4 33 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RAUWOLSCINE -4 33 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RAUWOLSCINE -4 33 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2142 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RX821002 -2 37 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4051 44 3H-RAUWOLSCINE -5 50 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-RAUWOLSCINE -5 50 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-RAUWOLSCINE -5 50 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-RAUWOLSCINE -5 50 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-RAUWOLSCINE -5 50 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
None 214957 0 UNDEFINED 1 3 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 390 1 2 4 3.1 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl None
12575 1949 28 3H-RAUWOLSCINE -5 17 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1949 28 3H-RAUWOLSCINE -5 17 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1949 28 3H-RAUWOLSCINE -5 17 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
2389 3267 114 3H-RAUWOLSCINE -87 68 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 3H-RAUWOLSCINE -87 68 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 3H-RAUWOLSCINE -87 68 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 3H-RAUWOLSCINE -87 68 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 3H-RAUWOLSCINE -87 68 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
164512323 214250 0 3H-RX821002 -18 5 Pig 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RX821002 -18 5 Pig 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
46780481 107032 18 3H-CLONIDINE -47 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107032 18 3H-CLONIDINE -47 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107032 18 3H-CLONIDINE -47 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107032 18 3H-CLONIDINE -47 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
521 1372 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1372 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1372 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1372 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1372 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
31101 719 39 3H-RX821002 -12 36 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 719 39 3H-RX821002 -12 36 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 719 39 3H-RX821002 -12 36 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 719 39 3H-RX821002 -12 36 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 719 39 3H-RX821002 -12 36 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
202 1475 0 UNDEFINED -9 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
60835 1475 0 UNDEFINED -9 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
972 1475 0 UNDEFINED -9 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
CHEMBL1175 1475 0 UNDEFINED -9 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
DB00476 1475 0 UNDEFINED -9 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
165193 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
2303 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
4946 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
564 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
62882 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
63 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
66366 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
91536 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
DB00571 3126 60 3H-RAUWOLSCINE -1000 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
104870 98410 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98410 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98410 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5656 201368 82 UNDEFINED -25 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 201368 82 UNDEFINED -25 43 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
54841 201428 51 UNDEFINED -1 30 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
CHEMBL641 201428 51 UNDEFINED -1 30 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
3075702 215584 0 3H-RAUWOLSCINE -2 37 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 198 3 1 3 1.5 C1CNC1COC2=CN=C(C=C2)Cl None
1499 2052 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
1499 2052 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 2052 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 2052 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 2052 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 2052 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 2052 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 2052 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 2052 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 2052 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
243 3141 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3141 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3141 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3141 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3141 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
2 3198 19 3H-RX821002 -2089 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
54562 3198 19 3H-RX821002 -2089 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
CHEMBL240773 3198 19 3H-RX821002 -2089 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
183782 3334 15 3H-RAUWOLSCINE -2398 15 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
237 3334 15 3H-RAUWOLSCINE -2398 15 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL85251 3334 15 3H-RAUWOLSCINE -2398 15 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
6917970 3622 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
8370 3622 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
CHEMBL487387 3622 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
2662 11264 124 3H-CLONIDINE -41 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
CHEMBL118 11264 124 3H-CLONIDINE -41 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
156391 46522 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL1200806 46522 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL154 46522 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
10624 69942 17 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
138543650 69942 17 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
CHEMBL194378 69942 17 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
2244 93785 96 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
CHEMBL25 93785 96 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
3663 99492 79 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
CHEMBL286494 99492 79 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
446220 132985 13 3H-CLONIDINE -1778 46 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 132985 13 3H-CLONIDINE -1778 46 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
5280343 187681 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 187681 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 187681 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
54676228 192864 108 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
CHEMBL527 192864 108 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
2771 193337 67 3H-RAUWOLSCINE -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
2771 193337 67 3H-RX821002 -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 193337 67 3H-RAUWOLSCINE -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 193337 67 3H-RX821002 -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 193337 67 3H-RAUWOLSCINE -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 193337 67 3H-RX821002 -120 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
4495 194850 87 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
CHEMBL56367 194850 87 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
54677470 198857 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL1256873 198857 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL599 198857 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
5281600 201327 85 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
CHEMBL63354 201327 85 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
5656 201368 82 3H-RX821002 -25 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 201368 82 3H-RX821002 -25 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
4054 203780 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL1699 203780 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL807 203780 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
None 214207 0 3H-RAUWOLSCINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 329 2 0 4 3.6 CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl None
104911 214239 0 3H-CLONIDINE -41686 38 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 530 7 0 5 5.1 COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl None
None 214246 0 3H-RAUWOLSCINE -6309 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 453 9 2 6 2.6 COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N.Cl None
25137849 214415 0 3H-CLONIDINE -2 41 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 214415 0 3H-CLONIDINE -2 41 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
31404 214429 0 3H-Yohimbine - 1 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 253 1 1 4 1.5 CCN1CCC2=C(CC1)OC(=N2)N.Cl.Cl None
127151 214477 0 3H-RX821002 -1584 10 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 313 6 1 4 3.2 CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3 None
None 214550 0 3H-CLONIDINE -1 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 240 7 4 6 -0.8 C(C(C(=O)O)N)SSCC(C(=O)O)N None
None 214551 0 3H-CLONIDINE -1 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 149 4 2 3 0.2 CSCCC(C(=O)O)N None
None 214552 0 3H-CLONIDINE -1 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 135 3 3 3 -0.3 C(CS)C(C(=O)O)N None
None 214553 0 3H-CLONIDINE -1 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 121 2 3 3 -0.7 C(C(C(=O)O)N)S None
None 214554 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 117 0 1 3 -0.0 C1CSC(=O)C1N None
None 214555 0 3H-CLONIDINE -1 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 153 3 3 3 -1.4 C(C(C(=O)O)N)S(=O)O None
None 214556 0 3H-CLONIDINE -1 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 3 3 4 -1.7 C(C(C(=O)O)N)S(=O)(=O)O None
None 214557 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 183 4 3 4 -1.3 C(CS(=O)(=O)O)C(C(=O)O)N None
None 214566 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 536 11 1 4 9.0 CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C None
4978 214567 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 520 1 7 9 4.3 CC1=CC(=C2C3=C1C4=C5C(=C(C=C4CO)O)C(=O)C6=C(C=C(C7=C6C5=C3C8=C7C(=CC(=C8C2=O)O)O)O)O)O None
None 214568 0 3H-CLONIDINE 2 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
None 214570 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 448 3 7 11 0.4 CC1C(C(C(C(O1)OC2=C(OC3=CC(=O)C=C(C3=C2O)O)C4=CC(=C(C=C4)O)O)O)O)O None
None 214581 0 3H-RX821002 -1862 19 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 246 2 1 4 1.6 CCCN1CCCC2C1CC3=CN=C(N=C3C2)N None
135269 214629 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 222 5 1 3 2.5 CCCCC(=O)OC1=CC=CC=C1C(=O)O None
23681059 214630 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O None
5018304 214631 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 317 4 1 3 0.0 C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+] None
3672 214632 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 206 4 1 1 3.1 CC(C)CC1=CC=C(C=C1)C(C)C(=O)O None
84003 214633 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 376 6 5 7 -0.0 C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O None
123619 214634 0 3H-CLONIDINE -1412 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 358 3 0 4 4.2 CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl None
119828 214635 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 5 1 5 3.5 CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C None
5090 214636 0 3H-CLONIDINE -1348 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 0 4 2.6 CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3 None
119607 214637 0 3H-CLONIDINE -97 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 1 4 3.0 CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N None
None 214638 0 3H-CLONIDINE -7 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 517 8 2 5 5.2 CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NCCC4=CC=C(C=C4)NC(=O)C None
None 214737 0 3H-CLONIDINE -4570 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 347 6 0 3 5.0 CC(=O)N(CC1=CC=CC=C1OC)C2=CC=CC=C2OC3=CC=CC=C3 None
11954224 214164 0 3H-CLONIDINE -446 60 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
1830 2542 39 3H-CLONIDINE -14 28 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2542 39 3H-CLONIDINE -14 28 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2542 39 3H-CLONIDINE -14 28 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2542 39 3H-CLONIDINE -14 28 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2542 39 3H-CLONIDINE -14 28 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
None 214251 0 3H-RAUWOLSCINE -19 3 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 401 6 1 5 0.6 CS(=O)(=O)NCCN(C1CCN2CCC3=CC=CC=C3C2C1)S(=O)(=O)C None
11079 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2683 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
179 396 107 125I-Clonidine -35 51 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2159 396 107 125I-Clonidine -35 51 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
963 396 107 125I-Clonidine -35 51 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
CHEMBL243712 396 107 125I-Clonidine -35 51 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
DB06288 396 107 125I-Clonidine -35 51 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
1353 1872 85 3H-CLONIDINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1353 1872 85 3H-RAUWOLSCINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1872 85 3H-CLONIDINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1872 85 3H-RAUWOLSCINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1872 85 3H-CLONIDINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1872 85 3H-RAUWOLSCINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1872 85 3H-CLONIDINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1872 85 3H-RAUWOLSCINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1872 85 3H-CLONIDINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1872 85 3H-RAUWOLSCINE -190 86 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
4209 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 3H-RX821002 -1862 34 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
None 214580 0 3H-RX821002 -15 19 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 451 8 2 4 3.2 CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C None
1267 3732 43 3H-RAUWOLSCINE -52 28 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
3035905 3732 43 3H-RAUWOLSCINE -52 28 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
CHEMBL260374 3732 43 3H-RAUWOLSCINE -52 28 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
None 214619 0 3H-RAUWOLSCINE -141 11 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 243 3 1 4 2.7 CCC1=CC2=C(O1)C=CC3=C2N(N=C3)CC(C)N None
5268 3586 34 3H-RAUWOLSCINE -60 18 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-RAUWOLSCINE -60 18 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-RAUWOLSCINE -60 18 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
68602 203406 72 35S-GTPGammaS -1 8 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203406 72 35S-GTPGammaS -1 8 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
164512323 214250 0 3H-RAUWOLSCINE -5 5 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RAUWOLSCINE -5 5 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
138107169 214163 0 3H-RAUWOLSCINE -6 23 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-RAUWOLSCINE -6 23 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
122211 458 0 3H-MK912 -239 6 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-MK912 -239 6 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
10297 26890 29 3H-CLONIDINE -5 44 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
CHEMBL136560 26890 29 3H-CLONIDINE -5 44 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
100 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
100 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3733 52 3H-CLONIDINE -33 56 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
44438148 93044 0 UNDEFINED -14 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
CHEMBL246229 93044 0 UNDEFINED -14 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
135409468 1996 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
333 1996 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
CHEMBL845 1996 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
2995 202690 49 3H-RAUWOLSCINE -12 23 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 202690 49 3H-RAUWOLSCINE -12 23 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 202690 49 3H-RAUWOLSCINE -12 23 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
None 214169 0 3H-MK912 -14 20 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
164512323 214250 0 3H-RX821002 -18 5 Pig 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RX821002 -18 5 Pig 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
44438166 93371 0 UNDEFINED -33 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
CHEMBL247664 93371 0 UNDEFINED -33 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
25058166 214171 0 3H-RX821002 -70 27 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
6852389 214171 0 3H-RX821002 -70 27 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
484 2804 45 35S-GTPGammaS -14 36 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 35S-GTPGammaS -14 36 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 35S-GTPGammaS -14 36 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
135398737 942 89 3H-CLONIDINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398737 942 89 3H-RAUWOLSCINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 3H-CLONIDINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 3H-RAUWOLSCINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 3H-CLONIDINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 3H-RAUWOLSCINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 3H-CLONIDINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 3H-RAUWOLSCINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 3H-CLONIDINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 3H-RAUWOLSCINE -26 92 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
7153 97557 74 3H-CLONIDINE -7 34 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
CHEMBL272942 97557 74 3H-CLONIDINE -7 34 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
1028 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 35S-GTPGammaS -30 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3658 4032 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4032 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4032 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4032 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4032 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
124 2921 44 35S-GTPGammaS -28 33 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 35S-GTPGammaS -28 33 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 35S-GTPGammaS -28 33 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 35S-GTPGammaS -28 33 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 35S-GTPGammaS -28 33 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
5524 214707 0 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
68602 203406 72 3H-MK912 -1 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203406 72 3H-MK912 -1 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
1613 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1613 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2306 44 3H-CLONIDINE -8 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 3H-CLONIDINE -87 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
68712 99861 57 35S-GTPGammaS -1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99861 57 35S-GTPGammaS -1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
186 1769 47 3H-CLONIDINE -354 17 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
71781 1769 47 3H-CLONIDINE -354 17 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
CHEMBL18972 1769 47 3H-CLONIDINE -354 17 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
16362 3064 67 3H-CLONIDINE -501 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3064 67 3H-CLONIDINE -501 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3064 67 3H-CLONIDINE -501 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3064 67 3H-CLONIDINE -501 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3064 67 3H-CLONIDINE -501 30 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
11079 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2683 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
2865 4064 67 3H-CLONIDINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
2865 4064 67 3H-RAUWOLSCINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4064 67 3H-CLONIDINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4064 67 3H-RAUWOLSCINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4064 67 3H-CLONIDINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4064 67 3H-RAUWOLSCINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4064 67 3H-CLONIDINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4064 67 3H-RAUWOLSCINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4064 67 3H-CLONIDINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4064 67 3H-RAUWOLSCINE -64 54 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
3294 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
3294 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1967 106 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
119570 3098 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3098 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3098 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3098 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3098 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
1223 938 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
2790 938 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
CHEMBL14690 938 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
134 2468 19 3H-CLONIDINE -74 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2468 19 3H-CLONIDINE -74 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2468 19 3H-CLONIDINE -74 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2468 19 3H-CLONIDINE -74 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2468 19 3H-CLONIDINE -74 68 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
16725934 146878 0 UNDEFINED -87 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
CHEMBL392992 146878 0 UNDEFINED -87 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
15897 2807 0 3H-CLONIDINE -134 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2807 0 3H-CLONIDINE -134 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2807 0 3H-CLONIDINE -134 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
103 4074 56 3H-RAUWOLSCINE -54 54 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4074 56 3H-RAUWOLSCINE -54 54 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4074 56 3H-RAUWOLSCINE -54 54 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4074 56 3H-RAUWOLSCINE -54 54 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4074 56 3H-RAUWOLSCINE -54 54 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2726 904 64 3H-CLONIDINE -64 73 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-CLONIDINE -64 73 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-CLONIDINE -64 73 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-CLONIDINE -64 73 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-CLONIDINE -64 73 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
1220 186 46 3H-RAUWOLSCINE -147 45 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
31 186 46 3H-RAUWOLSCINE -147 45 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
7 186 46 3H-RAUWOLSCINE -147 45 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
CHEMBL56 186 46 3H-RAUWOLSCINE -147 45 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
44438168 93372 0 UNDEFINED -53 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
CHEMBL247665 93372 0 UNDEFINED -53 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
2402 3306 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3306 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3306 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3306 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3306 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2142 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RX821002 -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
185 3931 54 3H-CLONIDINE -5888 38 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
5311271 3931 54 3H-CLONIDINE -5888 38 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
CHEMBL74355 3931 54 3H-CLONIDINE -5888 38 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
DB16351 3931 54 3H-CLONIDINE -5888 38 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
135398745 2858 108 3H-RAUWOLSCINE -93 66 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2858 108 3H-RAUWOLSCINE -93 66 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2858 108 3H-RAUWOLSCINE -93 66 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2858 108 3H-RAUWOLSCINE -93 66 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
484 2804 45 35S-GTPGammaS -9 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 35S-GTPGammaS -9 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 35S-GTPGammaS -9 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
68602 203406 72 35S-GTPGammaS -1 8 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203406 72 35S-GTPGammaS -1 8 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
None 214170 0 3H-RAUWOLSCINE -2 6 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 358 4 0 3 2.8 CCCS(=O)(=O)N(C)C1CCN2CCC3=CC=CC=C3C2C1.Cl None
123981 16267 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL123349 16267 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL536803 16267 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
2142 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RAUWOLSCINE -2 37 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2142 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RX821002 -1 37 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
1816 2494 99 3H-RAUWOLSCINE -33 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2494 99 3H-RAUWOLSCINE -33 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2494 99 3H-RAUWOLSCINE -33 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2494 99 3H-RAUWOLSCINE -33 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2494 99 3H-RAUWOLSCINE -33 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
1343 1850 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1850 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1850 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1850 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1850 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
2142 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 35S-GTPGammaS -2 37 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11079 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2683 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
25137849 214415 0 3H-CLONIDINE -2 41 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 214415 0 3H-CLONIDINE -2 41 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
11750482 146876 0 UNDEFINED -25 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
CHEMBL392991 146876 0 UNDEFINED -25 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
3952 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1849 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
2435 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 713 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
4209 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 3H-RAUWOLSCINE -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
44438161 146596 0 UNDEFINED -22 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
CHEMBL392771 146596 0 UNDEFINED -22 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
2337 3193 72 3H-RAUWOLSCINE -50 63 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3193 72 3H-RAUWOLSCINE -50 63 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3193 72 3H-RAUWOLSCINE -50 63 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3193 72 3H-RAUWOLSCINE -50 63 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3193 72 3H-RAUWOLSCINE -50 63 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
4209 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 3H-MK912 -3235 34 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
2695 3768 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3768 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3768 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3768 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3768 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2389 3267 114 3H-RAUWOLSCINE -87 68 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 3H-RAUWOLSCINE -87 68 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 3H-RAUWOLSCINE -87 68 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 3H-RAUWOLSCINE -87 68 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 3H-RAUWOLSCINE -87 68 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
3658 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
103 4074 56 3H-CLONIDINE -54 54 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4074 56 3H-CLONIDINE -54 54 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4074 56 3H-CLONIDINE -54 54 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4074 56 3H-CLONIDINE -54 54 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4074 56 3H-CLONIDINE -54 54 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
523 4031 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4031 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4031 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4031 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
135398737 942 89 3H-RAUWOLSCINE -26 92 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 3H-RAUWOLSCINE -26 92 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 3H-RAUWOLSCINE -26 92 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 3H-RAUWOLSCINE -26 92 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 3H-RAUWOLSCINE -26 92 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2695 3768 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3768 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3768 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3768 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3768 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2803 939 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
124 2921 44 35S-GTPGammaS -28 33 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 35S-GTPGammaS -28 33 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 35S-GTPGammaS -28 33 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 35S-GTPGammaS -28 33 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 35S-GTPGammaS -28 33 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
3658 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4032 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
2726 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
1615 167217 22 3H-CLONIDINE -6 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
CHEMBL43048 167217 22 3H-CLONIDINE -6 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
2726 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-RAUWOLSCINE -64 73 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
44438152 93162 0 UNDEFINED -134 3 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
CHEMBL246639 93162 0 UNDEFINED -134 3 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
162265 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
162265 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200578 19 3H-CLONIDINE -12 45 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
5268 3586 34 3H-RAUWOLSCINE -60 18 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-RAUWOLSCINE -60 18 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-RAUWOLSCINE -60 18 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
None 214476 0 3H-CLONIDINE -30199 30 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
2216 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
102 4051 44 3H-RX821002 -5 50 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-RX821002 -5 50 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-RX821002 -5 50 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-RX821002 -5 50 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-RX821002 -5 50 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
68602 203406 72 3H-RX821002 -1 8 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203406 72 3H-RX821002 -1 8 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
124 2921 44 3H-RX821002 -16 33 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RX821002 -16 33 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RX821002 -16 33 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RX821002 -16 33 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RX821002 -16 33 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2921 44 3H-RAUWOLSCINE -4 33 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RAUWOLSCINE -4 33 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RAUWOLSCINE -4 33 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RAUWOLSCINE -4 33 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RAUWOLSCINE -4 33 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
5268 3586 34 3H-RX821002 -10 18 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-RX821002 -10 18 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-RX821002 -10 18 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
68602 203406 72 35S-GTPGammaS 1 8 Mouse 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203406 72 35S-GTPGammaS 1 8 Mouse 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
138107169 214163 0 3H-RAUWOLSCINE -6 23 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-RAUWOLSCINE -6 23 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214169 0 3H-RAUWOLSCINE -14 20 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
102 4051 44 3H-MK912 -5 50 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-MK912 -5 50 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-MK912 -5 50 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-MK912 -5 50 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-MK912 -5 50 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
138107169 214163 0 3H-MK912 -6 23 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 3H-MK912 -6 23 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
115237 55281 113 3H-RAUWOLSCINE -44 55 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55281 113 3H-RAUWOLSCINE -44 55 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
122295 9760 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9760 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
4209 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
162265 200578 19 3H-CLONIDINE -12 45 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200578 19 3H-CLONIDINE -12 45 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200578 19 3H-CLONIDINE -12 45 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
1212 1624 45 3H-RAUWOLSCINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1624 45 3H-RAUWOLSCINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1624 45 3H-RAUWOLSCINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1624 45 3H-RAUWOLSCINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1624 45 3H-RAUWOLSCINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
11225732 93211 0 UNDEFINED -16 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
CHEMBL246852 93211 0 UNDEFINED -16 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
2803 939 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
5524 214707 0 35S-GTPGammaS 1 4 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
1212 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1212 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1624 45 3H-CLONIDINE -165 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2858 108 3H-CLONIDINE -93 66 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
4209 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 3H-RAUWOLSCINE -3235 34 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
133621 1973 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
3470 1973 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
CHEMBL347695 1973 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
523 4031 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4031 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4031 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4031 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
122295 9760 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9760 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
None 214476 0 3H-CLONIDINE -30199 30 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
122295 9760 6 3H-RX821002 -1 9 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9760 6 3H-RX821002 -1 9 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
2803 939 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
124 2921 44 3H-Yohimbine -16 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-Yohimbine -16 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-Yohimbine -16 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-Yohimbine -16 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-Yohimbine -16 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
138107169 214163 0 35S-GTPGammaS -97 23 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214163 0 35S-GTPGammaS -97 23 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
2337 3193 72 125I-Clonidine -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3193 72 3H-CLONIDINE -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3193 72 125I-Clonidine -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3193 72 3H-CLONIDINE -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3193 72 125I-Clonidine -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3193 72 3H-CLONIDINE -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3193 72 125I-Clonidine -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3193 72 3H-CLONIDINE -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3193 72 125I-Clonidine -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3193 72 3H-CLONIDINE -50 63 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
122211 458 0 3H-RX821002 -229 6 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RX821002 -229 6 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
104870 98410 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98410 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98410 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
484 2804 45 3H-RX821002 -14 36 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 3H-RX821002 -14 36 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 3H-RX821002 -14 36 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
1524 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2141 89 3H-RAUWOLSCINE -288 52 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
3337 214431 0 3H-CLONIDINE -27 41 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214431 0 3H-CLONIDINE -27 41 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214431 0 3H-CLONIDINE -27 41 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214431 0 3H-CLONIDINE -27 41 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
67409 214253 0 3H-RAUWOLSCINE -7 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
8966 214253 0 3H-RAUWOLSCINE -7 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
1028 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 35S-GTPGammaS -72 30 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
484 2804 45 35S-GTPGammaS -9 36 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 35S-GTPGammaS -9 36 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 35S-GTPGammaS -9 36 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
104870 98410 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98410 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98410 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
24840389 114701 3 3H-RX821002 -295 16 Rat 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 415 9 0 4 4.6 CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1 None
CHEMBL334529 114701 3 3H-RX821002 -295 16 Rat 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 415 9 0 4 4.6 CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1 None
2142 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2142 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RAUWOLSCINE -2 37 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
931 214706 0 35S-GTPGammaS -1 4 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
115237 55281 113 3H-CLONIDINE -44 55 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55281 113 3H-CLONIDINE -44 55 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
135 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
12057539 206291 39 None -9 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
3661 206291 39 None -9 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
CHEMBL9751 206291 39 None -9 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
124 2921 44 3H-RAUWOLSCINE -4 33 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-RAUWOLSCINE -4 33 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-RAUWOLSCINE -4 33 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-RAUWOLSCINE -4 33 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-RAUWOLSCINE -4 33 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2803 939 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
44438147 93043 0 UNDEFINED -20 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
CHEMBL246228 93043 0 UNDEFINED -20 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
10836 14314 13 3H-CLONIDINE -2 9 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14314 13 3H-CLONIDINE -2 9 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
44438167 148426 0 UNDEFINED -52 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
CHEMBL394218 148426 0 UNDEFINED -52 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
2435 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 713 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
100 3733 52 3H-RAUWOLSCINE -33 56 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3733 52 3H-RAUWOLSCINE -33 56 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3733 52 3H-RAUWOLSCINE -33 56 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3733 52 3H-RAUWOLSCINE -33 56 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3733 52 3H-RAUWOLSCINE -33 56 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
44438165 166220 0 UNDEFINED -48 3 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
CHEMBL428407 166220 0 UNDEFINED -48 3 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
135 2486 38 3H-RAUWOLSCINE -4 58 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2486 38 3H-RAUWOLSCINE -4 58 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2486 38 3H-RAUWOLSCINE -4 58 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2486 38 3H-RAUWOLSCINE -4 58 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2486 38 3H-RAUWOLSCINE -4 58 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
164512323 214250 0 3H-RAUWOLSCINE -5 5 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RAUWOLSCINE -5 5 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
135398745 2858 108 3H-RAUWOLSCINE -93 66 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2858 108 3H-RAUWOLSCINE -93 66 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2858 108 3H-RAUWOLSCINE -93 66 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2858 108 3H-RAUWOLSCINE -93 66 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1353 1872 85 3H-RAUWOLSCINE -190 86 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1872 85 3H-RAUWOLSCINE -190 86 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1872 85 3H-RAUWOLSCINE -190 86 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1872 85 3H-RAUWOLSCINE -190 86 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1872 85 3H-RAUWOLSCINE -190 86 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
2435 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 713 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5280805 84967 76 None -28 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
Drug Central 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O None
CHEMBL226335 84967 76 None -28 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
Drug Central 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O None
1210 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
1213 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
2725 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
33036 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
4411 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
616 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
6976 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
716121 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
90475904 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1201353 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1554789 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL505 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
DB01114 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
DB13679 903 45 None -263 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
3823 49936 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 49936 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 49936 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
28417 39784 48 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
CHEMBL1479 39784 48 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
3652 45968 62 None -1 9 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
CHEMBL1535 45968 62 None -1 9 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
135 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2486 38 3H-RAUWOLSCINE -4 58 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1960 2805 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2805 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2805 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2805 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2805 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
4158 203620 21 None -2 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 203620 21 None -2 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 203620 21 None -2 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
448537 159691 86 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 159691 86 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
2812 4696 96 None -32 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 4696 96 None -32 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
2719 902 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
5535 902 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
607 902 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
CHEMBL76 902 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
DB00608 902 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
10836 14314 13 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14314 13 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
4209 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 None -1862 34 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
6040 214252 0 3H-RAUWOLSCINE -4 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 233 2 0 3 2.3 C1CCN(CC1)CC2COC3=CC=CC=C3O2 None
2337 3193 72 None -50 63 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3193 72 None -50 63 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3193 72 None -50 63 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3193 72 None -50 63 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3193 72 None -50 63 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5268 3586 34 3H-RAUWOLSCINE -60 18 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-RAUWOLSCINE -60 18 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-RAUWOLSCINE -60 18 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
4211 57502 81 None -1 4 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 None
CHEMBL1670 57502 81 None -1 4 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 None
1443 1989 30 None -23 11 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 1989 30 None -23 11 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 1989 30 None -23 11 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 1989 30 None -23 11 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 1989 30 None -23 11 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
1549008 203957 81 None - 1 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 None
CHEMBL822 203957 81 None - 1 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 None
121850 716 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
525 716 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
CHEMBL216097 716 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
3598 187228 73 None -2 7 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl None
CHEMBL496 187228 73 None -2 7 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl None
2402 3306 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3306 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3306 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3306 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3306 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2247 502 77 None -58 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 502 77 None -58 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 502 77 None -58 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 502 77 None -58 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 502 77 None -58 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
5198 19220 46 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 None
CHEMBL12948 19220 46 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 None
3117 206096 100 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 206096 100 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
4209 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 None -616 34 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
3198 203792 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 203792 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 203792 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
16362 3064 67 None -501 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3064 67 None -501 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3064 67 None -501 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3064 67 None -501 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3064 67 None -501 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
5318 15385 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1200348 15385 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1221 15385 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
5353853 17788 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
9556529 17788 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1262 17788 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
1836 2544 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
3340 2544 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
5281040 2544 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
CHEMBL787 2544 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
DB00471 2544 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
4189 205185 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1559 205185 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL91 205185 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
2406 99925 84 None -16 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
CHEMBL290106 99925 84 None -16 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
119584 2547 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
1848 2547 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
242 2547 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
CHEMBL60889 2547 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
DB11675 2547 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
2484 206542 64 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 None
CHEMBL990 206542 64 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 None
2342 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
331 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
7124 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
CHEMBL1201250 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
DB00767 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
2335 11728 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
8478 11728 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL1182210 11728 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL221753 11728 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
1227 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
2331 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
3957 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
4992 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
CHEMBL511 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
DB06691 2444 35 None -91 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
3168 9157 84 None -123 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 9157 84 None -123 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
1353 1872 85 None -190 86 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1872 85 None -190 86 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1872 85 None -190 86 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1872 85 None -190 86 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1872 85 None -190 86 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1830 2542 39 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2542 39 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2542 39 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2542 39 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2542 39 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
3151 1429 93 None -99 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1429 93 None -99 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1429 93 None -99 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1429 93 None -99 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1429 93 None -99 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
1782 2472 81 None -5 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
241 2472 81 None -5 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
4168 2472 81 None -5 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
CHEMBL86 2472 81 None -5 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
DB01233 2472 81 None -5 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
135398737 942 89 3H-RAUWOLSCINE -26 92 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 3H-RAUWOLSCINE -26 92 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 3H-RAUWOLSCINE -26 92 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 3H-RAUWOLSCINE -26 92 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 3H-RAUWOLSCINE -26 92 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2803 939 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
2105 2993 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 2993 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 2993 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 2993 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 2993 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1343 1850 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1850 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1850 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1850 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1850 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
15897 2807 0 3H-CLONIDINE -134 37 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2807 0 3H-CLONIDINE -134 37 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2807 0 3H-CLONIDINE -134 37 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
11957583 214430 0 3H-Yohimbine - 1 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 391 1 2 3 3.4 C1CN=C(N1)NC2=C(C=C(C=C2Cl)I)Cl.Cl None
2801 161313 56 3H-RX821002 -14 29 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL1200710 161313 56 3H-RX821002 -14 29 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL415 161313 56 3H-RX821002 -14 29 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
6852400 214150 0 3H-RAUWOLSCINE -131 22 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
73759726 214150 0 3H-RAUWOLSCINE -131 22 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
3337 214431 0 3H-CLONIDINE -27 41 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214431 0 3H-CLONIDINE -27 41 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214431 0 3H-CLONIDINE -27 41 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214431 0 3H-CLONIDINE -27 41 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
5268 3586 34 3H-MK912 -60 18 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-MK912 -60 18 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-MK912 -60 18 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
2726 904 64 3H-RAUWOLSCINE -64 73 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-RAUWOLSCINE -64 73 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-RAUWOLSCINE -64 73 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-RAUWOLSCINE -64 73 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-RAUWOLSCINE -64 73 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
4158 203620 21 125I-Clonidine -2 21 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 203620 21 125I-Clonidine -2 21 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 203620 21 125I-Clonidine -2 21 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
484 2804 45 3H-Yohimbine -14 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 3H-Yohimbine -14 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 3H-Yohimbine -14 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
3952 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1849 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
1222 1626 44 3H-RAUWOLSCINE -100 33 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1626 44 3H-RAUWOLSCINE -100 33 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1626 44 3H-RAUWOLSCINE -100 33 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1626 44 3H-RAUWOLSCINE -100 33 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1626 44 3H-RAUWOLSCINE -100 33 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
523 4031 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4031 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4031 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4031 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
2142 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-RAUWOLSCINE -2 37 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11634155 190871 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
6018 190871 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
CHEMBL519344 190871 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
463 1373 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1373 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1373 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1373 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1373 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
237 203147 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL546257 203147 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL554190 203147 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL7568 203147 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
2181 3067 0 None -58 35 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3067 0 None -58 35 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3067 0 None -58 35 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3067 0 None -58 35 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3067 0 None -58 35 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
1530 2142 44 None -70 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
3827 2142 44 None -70 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
7206 2142 44 None -70 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
CHEMBL534 2142 44 None -70 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
DB00920 2142 44 None -70 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
4601 205010 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL1201023 205010 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL900 205010 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
5467 204202 40 None -6 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC None
CHEMBL84158 204202 40 None -6 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC None
1577 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
164512405 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
2537 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
5355 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
5501 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
643497 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
688272 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
958 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
960 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL196677 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL26 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL267044 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
DB00391 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
DB16021 3634 104 None -2 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
657255 197396 29 None -10 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 None
CHEMBL588119 197396 29 None -10 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 None
3157 1437 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1437 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1437 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1437 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1437 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
1016 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 3678 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
4011 81982 43 None -35 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 81982 43 None -35 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
26757 206229 29 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
CHEMBL972 206229 29 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
219050 3309 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
52 3309 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
CHEMBL431367 3309 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
240 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 929 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
214 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3787 52 None -75 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
209 2996 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 2996 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 2996 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 2996 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 2996 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2435 3520 78 None -123 49 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3520 78 None -123 49 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3520 78 None -123 49 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3520 78 None -123 49 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3520 78 None -123 49 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1042 1544 20 None -97 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
148 1544 20 None -97 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
443884 1544 20 None -97 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
CHEMBL119443 1544 20 None -97 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
DB01253 1544 20 None -97 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
2726 904 64 None -64 73 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 None -64 73 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 None -64 73 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 None -64 73 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 None -64 73 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
134 2468 19 None -74 68 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2468 19 None -74 68 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2468 19 None -74 68 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2468 19 None -74 68 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2468 19 None -74 68 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
2351 3222 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 3222 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 3222 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 3222 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 3222 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
150 2463 18 None -45 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
1764 2463 18 None -45 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
8226 2463 18 None -45 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
CHEMBL1201356 2463 18 None -45 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
DB00353 2463 18 None -45 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
6726 1249 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
7151 1249 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
749 1249 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL648 1249 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB01176 1249 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
1222 1626 44 None -100 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1626 44 None -100 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1626 44 None -100 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1626 44 None -100 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1626 44 None -100 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
6075 149563 36 None -11 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 149563 36 None -11 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
3584 3706 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3706 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3706 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3706 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3706 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
66265 93566 12 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 93566 12 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
2801 161313 56 None -14 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL1200710 161313 56 None -14 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL415 161313 56 None -14 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
4735 193435 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL361506 193435 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL55 193435 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
1225 1438 24 None -22 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1438 24 None -22 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1438 24 None -22 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1438 24 None -22 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1438 24 None -22 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
2865 4064 67 None -64 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4064 67 None -64 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4064 67 None -64 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4064 67 None -64 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4064 67 None -64 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
41 1621 0 3H-RX821002 -5 17 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1621 0 3H-RX821002 -5 17 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1621 0 3H-RX821002 -5 17 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
2142 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 3H-PRAZOSIN -2 37 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4051 44 3H-RX821002 -5 50 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-RX821002 -5 50 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-RX821002 -5 50 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-RX821002 -5 50 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-RX821002 -5 50 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
191 399 92 None -41 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 399 92 None -41 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 399 92 None -41 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 399 92 None -41 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 399 92 None -41 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3561 18871 34 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
CHEMBL1289 18871 34 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
4098 32274 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1255739 32274 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1411979 32274 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
164512323 214250 0 3H-RAUWOLSCINE -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RAUWOLSCINE -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
441383 20118 54 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 20118 54 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
1548955 88139 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
2800 88139 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
CHEMBL2355051 88139 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
135398745 2858 108 None -93 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2858 108 None -93 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2858 108 None -93 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2858 108 None -93 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1212 1624 45 None -165 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1624 45 None -165 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1624 45 None -165 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1624 45 None -165 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1624 45 None -165 66 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3389 215972 0 None -1 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
46780481 107032 18 3H-RAUWOLSCINE -47 54 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107032 18 3H-RAUWOLSCINE -47 54 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107032 18 3H-RAUWOLSCINE -47 54 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107032 18 3H-RAUWOLSCINE -47 54 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3191 102372 93 None -8 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 102372 93 None -8 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
1028 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 None -30 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
4543 169972 36 None -8 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
CHEMBL1201156 169972 36 None -8 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
CHEMBL445 169972 36 None -8 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
162265 200578 19 None -12 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200578 19 None -12 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200578 19 None -12 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
213 3780 50 None -10 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3780 50 None -10 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3780 50 None -10 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3780 50 None -10 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3780 50 None -10 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2286 3122 48 None -13 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 3122 48 None -13 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 3122 48 None -13 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 3122 48 None -13 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 3122 48 None -13 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
2695 3768 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3768 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3768 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3768 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3768 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2162 41258 97 None 1 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
CHEMBL1491 41258 97 None 1 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
12488 1619 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 1619 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 1619 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 1619 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
2520 202301 65 None -6 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL1280 202301 65 None -6 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL6966 202301 65 None -6 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
4209 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 None -3235 34 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
1201549 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
103 4074 56 None -54 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4074 56 None -54 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4074 56 None -54 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4074 56 None -54 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4074 56 None -54 54 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
11057 175565 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
3468 175565 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL459265 175565 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL64894 175565 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
1547484 925 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 925 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 925 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 925 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 925 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
3294 1967 106 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1967 106 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1967 106 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1967 106 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1967 106 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
12574 2557 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
4810 2557 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
CHEMBL19236 2557 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
DB09242 2557 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
1613 2306 44 None -8 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2306 44 None -8 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2306 44 None -8 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2306 44 None -8 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2306 44 None -8 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
15387 214199 0 None -1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F None
5472 204094 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL1717 204094 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL833 204094 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
100 3733 52 None -33 56 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3733 52 None -33 56 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3733 52 None -33 56 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3733 52 None -33 56 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3733 52 None -33 56 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
180 397 50 None -58 39 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 397 50 None -58 39 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 397 50 None -58 39 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 397 50 None -58 39 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 397 50 None -58 39 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2284 3121 27 None -12 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3121 27 None -12 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3121 27 None -12 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3121 27 None -12 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3121 27 None -12 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
228 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
104870 98410 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98410 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98410 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
68617 203806 60 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 203806 60 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 203806 60 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
4209 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 None -173 34 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
277 1269 55 None -33 46 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1269 55 None -33 46 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1269 55 None -33 46 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1269 55 None -33 46 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1269 55 None -33 46 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
15897 2807 0 3H-CLONIDINE -134 37 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2807 0 3H-CLONIDINE -134 37 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2807 0 3H-CLONIDINE -134 37 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
2803 939 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
2803 939 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
102 4051 44 35S-GTPGammaS -154 50 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 35S-GTPGammaS -154 50 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 35S-GTPGammaS -154 50 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 35S-GTPGammaS -154 50 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 35S-GTPGammaS -154 50 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2683 3762 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3762 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3762 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3762 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3762 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
102 4051 44 3H-PRAZOSIN -158 50 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-PRAZOSIN -158 50 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-PRAZOSIN -158 50 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-PRAZOSIN -158 50 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-PRAZOSIN -158 50 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2726 904 64 3H-RX821002 -38 73 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-RX821002 -38 73 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-RX821002 -38 73 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-RX821002 -38 73 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-RX821002 -38 73 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2435 3520 78 3H-CLONIDINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
2435 3520 78 3H-RAUWOLSCINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3520 78 3H-CLONIDINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3520 78 3H-RAUWOLSCINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3520 78 3H-CLONIDINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3520 78 3H-RAUWOLSCINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3520 78 3H-CLONIDINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3520 78 3H-RAUWOLSCINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3520 78 3H-CLONIDINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3520 78 3H-RAUWOLSCINE -123 49 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1028 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 3H-Yohimbine -120 30 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
214 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3787 52 3H-CLONIDINE -75 30 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
None 214564 0 3H-CLONIDINE -8 41 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 149 2 1 2 1.2 CC(C(=O)C1=CC=CC=C1)N None
2202 3071 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3071 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3071 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3071 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3071 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
212 3734 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 3734 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 3734 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 3734 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 3734 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
242 467 117 None -26 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 None -26 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 None -26 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 None -26 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 None -26 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
135398737 942 89 None -26 92 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 None -26 92 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 None -26 92 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 None -26 92 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 None -26 92 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
26987 934 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 934 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 934 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 934 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 934 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
1960 2805 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2805 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2805 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2805 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2805 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
2274 3112 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3112 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3112 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3112 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3112 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
124 2921 44 35S-GTPGammaS -4 33 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 35S-GTPGammaS -4 33 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 35S-GTPGammaS -4 33 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 35S-GTPGammaS -4 33 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 35S-GTPGammaS -4 33 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2105 2993 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 2993 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 2993 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 2993 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 2993 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
117590588 96064 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
14969 96064 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
CHEMBL262777 96064 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
102 4051 44 None -47 50 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 None -47 50 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 None -47 50 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 None -47 50 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 None -47 50 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
213046 2343 55 None -12 9 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
4168 2343 55 None -12 9 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
7461 2343 55 None -12 9 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
CHEMBL1237021 2343 55 None -12 9 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
DB08815 2343 55 None -12 9 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
2585 788 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 788 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 788 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 788 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 788 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
68712 99861 57 None -1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99861 57 None -1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
5524 214707 0 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
240 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 929 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2389 3267 114 None -44 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 None -44 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 None -44 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 None -44 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 None -44 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
6761 67442 17 None -6 18 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 67442 17 None -6 18 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
133 2450 48 None -23 43 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 2450 48 None -23 43 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 2450 48 None -23 43 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 2450 48 None -23 43 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 2450 48 None -23 43 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
124 2921 44 None -16 33 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 None -16 33 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 None -16 33 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 None -16 33 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 None -16 33 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
11079 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2683 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
1816 2494 99 None -33 17 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2494 99 None -33 17 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2494 99 None -33 17 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2494 99 None -33 17 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2494 99 None -33 17 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
135398737 942 89 None -10 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 None -10 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 None -10 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 None -10 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 None -10 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
931 214706 0 35S-GTPGammaS -2 4 Mouse 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
135 2486 38 None -5 58 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2486 38 None -5 58 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2486 38 None -5 58 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2486 38 None -5 58 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2486 38 None -5 58 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
3952 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1849 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
11978813 712 72 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 712 72 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 712 72 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 712 72 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 712 72 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
3658 4032 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4032 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4032 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4032 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4032 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
10219 188200 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL493439 188200 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL50588 188200 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
129211 3680 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3680 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3680 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3680 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3680 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
37 764 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 764 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 764 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 764 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 764 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
115237 55281 113 None -44 55 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55281 113 None -44 55 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
2216 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
41 1621 0 3H-MK912 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
41 1621 0 3H-RX821002 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1621 0 3H-MK912 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1621 0 3H-RX821002 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1621 0 3H-MK912 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1621 0 3H-RX821002 -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
102 4051 44 3H-MK912 -5 50 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 3H-MK912 -5 50 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 3H-MK912 -5 50 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 3H-MK912 -5 50 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 3H-MK912 -5 50 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
None 214568 0 3H-CLONIDINE 2 28 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
68712 99861 57 35S-GTPGammaS -9 5 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99861 57 35S-GTPGammaS -9 5 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
None 214356 0 3H-CLONIDINE -758 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 772 16 4 10 5.5 CN(C)CCONC(=CC=C1C=CC(=O)C=C1)C2=CC=CC=C2F.CN(C)CCONC(=CC=C1C=CC(=O)C=C1)C2=CC=CC=C2F.C(=CC(=O)O)C(=O)O None
213 3780 50 125I-Clonidine -10 44 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3780 50 125I-Clonidine -10 44 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3780 50 125I-Clonidine -10 44 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3780 50 125I-Clonidine -10 44 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3780 50 125I-Clonidine -10 44 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
242 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
242 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 3H-CLONIDINE -26 52 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
119570 3098 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3098 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3098 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3098 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3098 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2726 904 64 3H-RAUWOLSCINE -64 73 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 904 64 3H-RAUWOLSCINE -64 73 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 904 64 3H-RAUWOLSCINE -64 73 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 904 64 3H-RAUWOLSCINE -64 73 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 904 64 3H-RAUWOLSCINE -64 73 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
135398737 942 89 3H-RAUWOLSCINE -26 92 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 942 89 3H-RAUWOLSCINE -26 92 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 942 89 3H-RAUWOLSCINE -26 92 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 942 89 3H-RAUWOLSCINE -26 92 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 942 89 3H-RAUWOLSCINE -26 92 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
11954259 214191 0 3H-CLONIDINE -263 44 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
4209 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3102 71 35S-GTPGammaS -3235 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
31101 719 39 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 719 39 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 719 39 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 719 39 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 719 39 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2389 3267 114 None -87 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3267 114 None -87 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3267 114 None -87 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3267 114 None -87 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3267 114 None -87 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
12575 1949 28 UNDEFINED -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1949 28 UNDEFINED -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1949 28 UNDEFINED -5 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
1209 1620 69 None -1 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 1620 69 None -1 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 1620 69 None -1 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 1620 69 None -1 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 1620 69 None -1 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
5268 3586 34 3H-RAUWOLSCINE -60 18 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3586 34 3H-RAUWOLSCINE -60 18 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3586 34 3H-RAUWOLSCINE -60 18 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
135 2486 38 None -4 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2486 38 None -4 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2486 38 None -4 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2486 38 None -4 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2486 38 None -4 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2142 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 None -2 37 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4051 44 None -15 50 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 None -15 50 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 None -15 50 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 None -15 50 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 None -15 50 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
1593 2298 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
30668 2298 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
9868 2298 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
CHEMBL17860 2298 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
DB04948 2298 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
2803 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
134551 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
2216 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
None 214254 0 3H-RAUWOLSCINE 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 200 3 1 1 2.8 CC1=C(C(=CC=C1)C)CCC2=CN=CN2 None
2142 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 None -2 37 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
124 2921 44 None -5 33 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 None -5 33 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 None -5 33 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 None -5 33 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 None -5 33 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
164512323 214250 0 3H-RAUWOLSCINE -5 5 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214250 0 3H-RAUWOLSCINE -5 5 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
11954259 214191 0 3H-CLONIDINE -263 44 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
3337 214431 0 3H-CLONIDINE -27 41 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214431 0 3H-CLONIDINE -27 41 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214431 0 3H-CLONIDINE -27 41 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214431 0 3H-CLONIDINE -27 41 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
209 2996 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 2996 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 2996 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 2996 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 2996 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2803 939 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
11293787 147669 0 UNDEFINED -77 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
CHEMBL393597 147669 0 UNDEFINED -77 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
2181 3067 0 3H-RAUWOLSCINE -58 35 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3067 0 3H-RAUWOLSCINE -58 35 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3067 0 3H-RAUWOLSCINE -58 35 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3067 0 3H-RAUWOLSCINE -58 35 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3067 0 3H-RAUWOLSCINE -58 35 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2202 3071 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3071 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3071 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3071 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3071 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
None 214569 0 UNDEFINED -8 28 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
2142 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3035 54 None 1 37 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11954224 214164 0 None -446 60 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
107715 199250 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 199250 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 199250 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
931 214706 0 35S-GTPGammaS -2 4 Mouse 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
102 4051 44 None -5 50 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4051 44 None -5 50 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4051 44 None -5 50 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4051 44 None -5 50 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4051 44 None -5 50 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2803 939 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 939 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 939 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 939 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 939 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
10531 1387 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 1387 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 1387 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 1387 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 1387 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
2601 3709 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3709 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3709 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3709 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3709 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
124 2921 44 None -4 33 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 None -4 33 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 None -4 33 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 None -4 33 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 None -4 33 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2921 44 3H-MK912 -4 33 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2921 44 3H-MK912 -4 33 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2921 44 3H-MK912 -4 33 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2921 44 3H-MK912 -4 33 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2921 44 3H-MK912 -4 33 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
12575 1949 28 35S-GTPGammaS -5 17 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1949 28 35S-GTPGammaS -5 17 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1949 28 35S-GTPGammaS -5 17 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
1588 2284 24 None 2 44 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2284 24 None 2 44 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2284 24 None 2 44 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2284 24 None 2 44 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2284 24 None 2 44 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
1576 214565 0 3H-CLONIDINE -15 41 Human 5.0 pKi = 5.0 Binding
NoneNone
PDSP KiDatabase 163 3 1 2 1.5 CC(C(=O)C1=CC=CC=C1)NC None
1343 1850 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1850 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1850 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1850 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1850 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
None 214569 0 3H-CLONIDINE -8 28 Human 5.0 pKi = 5.0 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
21830793 91389 5 3H-8-OH-DPAT -630 46 Bovine 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
CHEMBL2413154 91389 5 3H-8-OH-DPAT -630 46 Bovine 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
None 214255 0 3H-RAUWOLSCINE -16 3 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 334 4 1 4 4.6 CN(C)CCCN1C2=C(C=C(C=C2)O)SC3=C1C=C(C=C3)Cl None
484 2804 45 3H-RAUWOLSCINE -9 36 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2804 45 3H-RAUWOLSCINE -9 36 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2804 45 3H-RAUWOLSCINE -9 36 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
1593 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
30668 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
9868 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
CHEMBL17860 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
DB04948 2298 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
1816 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
4205 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
7241 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
CHEMBL654 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
DB00370 2494 99 None -33 17 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
2695 3768 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
5504 3768 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
7310 3768 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
CHEMBL770 3768 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
DB00797 3768 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
174174 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
260 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
320 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
CHEMBL517712 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
DB00572 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
1960 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
1960 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
1960 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
439260 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
439260 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
505 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
505 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
CHEMBL1437 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL1437 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
DB00368 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00368 2805 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
1028 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
1028 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
1028 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
139148732 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
139148732 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
479 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
479 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
5816 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
5816 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
CHEMBL679 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL679 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
DB00668 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00668 287 69 None -30 30 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
1343 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
1343 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
1343 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
3519 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
3519 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
522 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
522 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
CHEMBL862 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
CHEMBL862 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
DB01018 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
DB01018 1850 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
12575 1949 28 None -5 17 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
54459 1949 28 None -5 17 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
CHEMBL10316 1949 28 None -5 17 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
213046 2343 55 None -12 9 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
4168 2343 55 None -12 9 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
7461 2343 55 None -12 9 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
CHEMBL1237021 2343 55 None -12 9 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
DB08815 2343 55 None -12 9 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
2435 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
2435 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
2435 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
2435 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
2435 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
395 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
395 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
395 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
395 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
520 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
520 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
520 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
520 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
5386 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
5386 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
5386 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
5386 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
CHEMBL844 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
CHEMBL844 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
CHEMBL844 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
CHEMBL844 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
DB00484 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
DB00484 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
DB00484 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
DB00484 713 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
2803 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
2803 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
2803 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
2803 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
516 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
516 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
516 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
704 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
704 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
704 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
CHEMBL134 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
CHEMBL134 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
CHEMBL134 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
DB00575 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
DB00575 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
DB00575 939 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
124 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
124 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
124 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
124 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
2032 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
2032 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
2032 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
2032 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
4636 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
4636 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
4636 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
4636 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
CHEMBL762 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
CHEMBL762 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
CHEMBL762 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
CHEMBL762 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
DB00935 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
DB00935 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
DB00935 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
DB00935 2921 44 None -4 33 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
313 2642 0 None -2 6 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 29860464
121850 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
121850 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
525 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
525 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
CHEMBL216097 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
CHEMBL216097 716 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
2216 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
229 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
7117 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
CHEMBL647 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
DB00964 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
12576 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
71310 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
CHEMBL353972 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
DB11481 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
521 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
521 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
521 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
521 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
521 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
5311068 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
5311068 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
5311068 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
5311068 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
835 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
835 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
835 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
835 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
CHEMBL778 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
CHEMBL778 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
CHEMBL778 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
CHEMBL778 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
DB00633 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
DB00633 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
DB00633 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
DB00633 1372 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
108094 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
108094 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
526 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
526 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
528 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
528 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
CHEMBL10332 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
CHEMBL10332 3356 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
102 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
102 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
102 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
102 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
3659 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
3659 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
3659 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
3659 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
8969 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
8969 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
8969 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
8969 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL15245 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL15245 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
CHEMBL15245 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
CHEMBL15245 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
DB01392 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
DB01392 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
DB01392 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
DB01392 4051 44 None -5 50 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
2995 202690 49 None -12 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 202690 49 None -12 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 202690 49 None -12 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
179 396 107 None -35 51 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2159 396 107 None -35 51 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
963 396 107 None -35 51 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
CHEMBL243712 396 107 None -35 51 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
DB06288 396 107 None -35 51 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
3337 214431 0 None -27 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214431 0 None -27 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214431 0 None -27 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214431 0 None -27 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
119570 3098 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3098 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3098 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3098 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3098 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
46780481 107032 18 None -47 54 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107032 18 None -47 54 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107032 18 None -47 54 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107032 18 None -47 54 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1588 2284 24 None 2 44 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 2284 24 None 2 44 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 2284 24 None 2 44 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 2284 24 None 2 44 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 2284 24 None 2 44 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
523 4031 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
5707 4031 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
CHEMBL297362 4031 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
DB11477 4031 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
4209 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4209 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4209 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
4893 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4893 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4893 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
503 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
503 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
503 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
5385 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
5385 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
5385 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
CHEMBL2 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
CHEMBL2 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
CHEMBL2 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
DB00457 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
DB00457 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
DB00457 3102 71 None -3235 34 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
2726 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
2726 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
621 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
621 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
83 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
83 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
CHEMBL71 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
CHEMBL71 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
DB00477 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
DB00477 904 64 None -64 73 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
228 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
33 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
6005 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
CHEMBL53 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
DB00714 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
2202 3071 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
4850 3071 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
49 3071 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
CHEMBL1371770 3071 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
DB12478 3071 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
2105 2993 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
47811 2993 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
48 2993 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
CHEMBL531 2993 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
DB01186 2993 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
5268 3586 34 None -60 18 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
53 3586 34 None -60 18 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
CHEMBL300555 3586 34 None -60 18 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
37 764 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 764 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 764 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 764 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 764 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
31101 719 39 None -12 36 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
35 719 39 None -12 36 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
403 719 39 None -12 36 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
CHEMBL493 719 39 None -12 36 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
DB01200 719 39 None -12 36 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
499 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
499 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
499 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
5685 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
5685 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
5685 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
CHEMBL25554 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
CHEMBL25554 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
CHEMBL25554 4002 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
2142 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
2142 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
4920903 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
4920903 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
502 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
502 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
5775 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
5775 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
CHEMBL597 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
CHEMBL597 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
DB00692 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
DB00692 3035 54 None -2 37 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
136 3228 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
223 3228 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
643606 3228 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL10347 3228 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
2601 3709 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 3709 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 3709 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 3709 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 3709 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666